US20080161903A1 - Noncylindrical Drug Eluting Stent for Treating Vascular Bifurcations - Google Patents
Noncylindrical Drug Eluting Stent for Treating Vascular Bifurcations Download PDFInfo
- Publication number
- US20080161903A1 US20080161903A1 US12/050,068 US5006808A US2008161903A1 US 20080161903 A1 US20080161903 A1 US 20080161903A1 US 5006808 A US5006808 A US 5006808A US 2008161903 A1 US2008161903 A1 US 2008161903A1
- Authority
- US
- United States
- Prior art keywords
- stent
- deployment system
- stents
- proximal
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/954—Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9517—Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
- A61F2002/067—Y-shaped blood vessels modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
- A61F2002/9583—Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F2002/9665—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Abstract
A device and method for treating pathological narrowing of fluid-carrying conduits of the human body (such as blood vessels) in an area of a bifurcation is disclosed. In particular, a stent delivery system configured to carry one or more of a pair of dissimilar stents. At least one of the stents is particularly suited for treating a widened portion of a blood vessel immediately proximal to a bifurcation. The stent delivery system can also include a handpiece adapted to selectively deliver the stents.
Description
- This is divisional of U.S. application Ser. No. 10/435,096, filed May 9, 2003, now U.S. Pat. No. 7,344,556, which is a continuation of U.S. application Ser. No. 10/292,385, filed Nov. 11, 2002, which is a continuation-in-part of U.S. application Ser. No. 10/225,484, filed Aug. 20, 2002, now U.S. Pat. No. 7,238,197, which is a continuation-in-part of U.S. application Ser. No. 09/580,597, filed May 30, 2000, now U.S. Pat. No. 6,666,883, the disclosures of which are all incorporated by reference herein in their entireties.
- 1. Scope of the Invention
- The present invention relates to an apparatus permitting the treatment of bodily conduits, typically blood vessels, in an area of a bifurcation, e.g. in an area where a principal conduit separates into two secondary conduits. It also relates to equipment for positioning this apparatus.
- 2. Description of the Related Art
- It is known to treat narrowing of a rectilinear blood vessel by means of a radially expandable tubular device, commonly referred to as a stent. This stent is introduced in the unexpanded state into the internal lumen of the vessel, in particular by the percutaneous route, as far as the area of narrowing. Once in place, the stent is expanded in such a way as to support the vessel wall and thus re-establish the appropriate cross section of the vessel.
- Stent devices can be made of a non-elastic material, in which case the stent is expanded by an inflatable balloon on which it is engaged. Alternatively, the stent can be self-expanding, e.g. made of an elastic material. A self-expanding stent typically expands spontaneously when withdrawn from a sheath which holds it in a contracted state.
- For example, U.S. Pat. Nos. 4,733,065 and 4,806,062 illustrate existing stent devices and corresponding positioning techniques.
- A conventional stent is not entirely suitable for the treatment of a narrowing situated in the area of a bifurcation, since its engagement both in the principal conduit and in one of the secondary conduits can cause immediate or delayed occlusion of the other secondary conduit.
- It is known to reinforce a vascular bifurcation by means of a stent comprising first and second elements, each formed by helical winding of a metal filament. The first of the two elements has a first part having a diameter corresponding to the diameter of the principal vessel, and a second part having a diameter corresponding to the diameter of a first one of the secondary vessels. The first element is intended to be engaged in the principal vessel and the second element is intended to be engaged in the first secondary vessel. The second element has a diameter corresponding to the diameter of the second secondary vessel. After the first element has been put into place, the second element is then coupled to the first element by engaging one or more of its turns in the turns of the first element.
- This equipment permits reinforcement of the bifurcation but appears unsuitable for treating a vascular narrowing or an occlusive lesion, in view of its structure and of the low possibility of radial expansion of its two constituent elements.
- Moreover, the shape of the first element does not correspond to the shape of a bifurcation, which has a widened transitional zone between the end of the principal vessel and the ends of the secondary vessels. Thus, this equipment does not make it possible to fully support this wall or to treat a dissection in the area of this wall. Additionally, the separate positioning of these two elements is quite difficult.
- There is provided in accordance with one aspect of the present invention, a method of treating a vascular bifurcation of a main vessel into first and second branch vessels. The method comprises the steps of providing a delivery catheter having a stent thereon, the stent having a proximal end and a distal end and being self expandable to a configuration in which the proximal end has a smaller diameter than the distal end. The catheter is positioned such that the stent is at a treatment site within the main vessel, with the distal end adjacent the bifurcation. The stent is deployed in the main vessel such that the distal end communicates with both the first and the second branch vessels. A drug is eluted from the stent at the treatment site.
- In one implementation of the invention, the eluting a drug step includes eluting a smooth muscle cell proliferation inhibitor. In one aspect, the muscle cell proliferation inhibitor includes rapamycin. The eluting a drug step may comprise eluting angiopeptin, a platelet aggregation inhibitor, an anti-inflammatory agent, or an antibiotic agent. In another aspect, the eluting a drug step includes eluting paclitaxel. The deploying step may comprise removing a restraint from the stent and permitting the stent to self expand. The method may additionally comprise the step of deploying a second stent in one of the first and second branch vessels.
- In one implementation of the invention, the distal end of the stent expands to a diameter that is at least about 105% of the diameter of the proximal end of the stent. In certain applications, the distal end of the stent expands to a diameter that is at least about 110% of the diameter of the proximal end of the stent.
- In accordance with another aspect of the present invention, there is provided a deployment system for treating a bifurcation of a main vessel into first and second branch vessels. The deployment system comprises an elongate flexible body, having a proximal end and a distal end. A first stent is carried by the distal end of the body. A drug is releasably carried by the stent. A releasable restraint for restraining the stent is also carried on the body. The distal end of the stent is larger in diameter than the proximal end of the stent in an unconstrained expanded configuration.
- The deployment system may additionally comprise a guidewire lumen extending axially through at least a portion of the flexible body. The guidewire lumen has a proximal access port and a distal access port. In one implementation, the proximal access port is positioned along the flexible body, spaced distally apart from the proximal end. In another implementation, the proximal access port is positioned at the proximal end of the body.
- The releasable restraint may comprise an axially moveable control element extending along the length of the flexible body. The releasable restraint may comprise a tubular sheath for restraining the stent. The releasable restraint may include an axially moveable pull wire or a dissolvable media. In one aspect, the deployment system further includes a second stent that is carried by the distal end of the body. The first and second stents may have different expanded geometries from each other. In another aspect, the second stent has a substantially cylindrical unconstrained expanded configuration, having a proximal end, a distal end, and a substantially constant radius throughout.
- In yet another aspect of the present invention, the expanded diameter of the first stent tapers radially outwardly in the distal direction. In another aspect, the first and second stents are carried by the catheter such that release of the stents from the catheter causes the distal end of the first stent and the proximal end of the second stent, as implanted, to be separated by a distance of no more than about 4 mm.
- In accordance with a further aspect of the present invention, there is provided a method of treating a vascular bifurcation of a main vessel into first and second branch vessels. The method comprises the steps of deploying a substantially cylindrical stent in a first branch vessel which is distal to the bifurcation, and deploying a tapered stent in the main vessel, proximal to the bifurcation. The tapered stent tapers in a distal direction from a smaller proximal diameter to a larger distal diameter which faces the bifurcation. An active agent is delivered from at least one of the stents.
- In one aspect, the active agent comprises paclitaxel, rapamycin, or a smooth muscle cell proliferation inhibitor. In another aspect, the active agent comprises a platelet aggregation inhibitor, an anti-inflammatory agent, or an antibiotic agent. The active agent may include a calcium entry blocker, or an antimicrobial agent.
- All of these embodiments are intended to be within the scope of the present invention herein disclosed. These and other embodiments of the present invention will become readily apparent to those skilled in the art from the following detailed description of the preferred embodiments having reference to the attached figures, the invention not being limited to any particular embodiment(s) disclosed.
- Having thus summarized the general nature of the invention, certain preferred embodiments and modifications thereof will become apparent to those skilled in the art from the detailed description herein having reference to the attached figures, of which:
-
FIG. 1 is a side view of a first embodiment of a stent system shown in an expanded state; -
FIG. 2 is a perspective, partial cutaway view of the stent system ofFIG. 1 shown in a state of radial contraction, as disposed on a delivery catheter; -
FIG. 3 is a longitudinal sectional view of a bifurcation treatable by the stent system ofFIG. 1 ; -
FIG. 4 is a section view of the bifurcation ofFIG. 3 showing a delivery catheter positioned therein; -
FIG. 5 is a section view of the bifurcation ofFIG. 3 showing an embodiment of a stent system shown in a partially contracted state on a portion of a delivery catheter; -
FIG. 6 is a section view of the bifurcation ofFIG. 3 showing an embodiment of a stent system shown in an expanded and fully deployed state; -
FIG. 7 is a section view of a bifurcation presenting an aneurysm and an embodiment of a stent system shown deployed therein, -
FIG. 8 is a side view of a stent system according to a second embodiment shown in an expanded state; -
FIG. 9 is a plan view of a delivery catheter usable to deploy a stent system having certain features and advantages; -
FIG. 9A is an alternative embodiment of a proximal handpiece of the delivery catheter ofFIG. 9 ; -
FIG. 9B is an alternative embodiment of the delivery catheter ofFIG. 9 ; -
FIG. 9C is a section view of a portion of the delivery catheter ofFIG. 9 taken throughline 9C-9C and specifically showing an alternative pull wire lumen; -
FIG. 9D is a section view of a portion of the delivery catheter ofFIG. 9 taken throughline 9D-9D and specifically showing a retaining band; -
FIG. 9E is a detail view of a retraction band retention assembly of the delivery catheter ofFIG. 9 ; -
FIG. 10 is a partial cutaway view of a distal portion of the catheter ofFIG. 9 including a stent system disposed thereon; -
FIG. 10A is an alternative embodiment of a distal end assembly of the delivery catheter ofFIG. 9B ; -
FIG. 10B is a detail view of a distal portion of the outer sheath shown inFIG. 10 ; -
FIG. 10C is a section view taken along theline 10C-10C ofFIG. 10 ; -
FIG. 11A is a plan view of a transitional portion of the catheter ofFIG. 9 ; -
FIG. 11B is a cross sectional view of the transitional portion taken along theline 11B-11B ofFIG. 11A ; -
FIG. 11C is a transverse sectional view of the transitional portion taken along theline 11C-11C ofFIG. 11A ; -
FIG. 11D is a cross sectional view of the proximal shaft taken along theline 11D-11D ofFIG. 11A ; -
FIG. 12 is a side section view of a distal portion of an embodiment of a delivery catheter having certain features and advantages; -
FIG. 13 is a section view of a bifurcation showing an embodiment of a delivery catheter positioned therein; -
FIG. 14 is a section view of a bifurcation showing a first stent in a partially deployed state; -
FIG. 15 is a section view of a bifurcation showing a first stent in a fully deployed state; -
FIG. 16 is a section view of a bifurcation showing a second stent in a partially deployed state; -
FIG. 17 is a section view of a bifurcation showing a second stent in a fully deployed state; -
FIG. 18 is a section view of a bifurcation as inFIG. 17 , with a second branch stent deployed in the second branch; -
FIG. 19 is a schematic elevation view of a single-stent delivery system for delivering a cylindrical stent; -
FIG. 20 is a schematic elevation view of the single-stent delivery system ofFIG. 19 showing the sheath in a proximal detail view; -
FIG. 21 is a schematic elevation view of a single-stent delivery system for delivering a conical stent; and -
FIG. 22 is a schematic elevation view of the single-stent delivery system ofFIG. 21 showing the sheath in a proximal detail view. - As described above, the attached Figures illustrate a stent system and corresponding delivery system for use in treating vessels (e.g. conduits) within the human body at areas of bifurcations.
FIG. 3 shows abifurcation 30 in which a main conduit orvessel 32 separates into two secondary branch conduits orvessels 34. The stent system generally includes a pair of dissimilar stents specifically designed for use in an area of abifurcation 30. Such dissimilar stents are then disposed on an elongate catheter for insertion into the human body. The dissimilar stents may be self-expanding or manually expandable such as by a balloon about which the stents may be disposed as will be described in further detail below. -
FIG. 1 shows one embodiment of anexpandable stent system 10 permitting the treatment of bodily conduits in the area of a bifurcation such as that shown. Thestent system 10, shown in an expanded state inFIG. 1 , generally comprises first 12 and second 14 stent portions which may each be divided into two segments, thus creating foursuccessive segments first stent 12 is generally adapted to be disposed in a branch conduit orvessel 34 of a bifurcation, while thesecond stent 14 is generally adapted to be disposed in amain vessel 32. If desired, the segments may be connected to one another via one or more bridges ofmaterial 18. Thestents - According to the illustrated embodiment, the
stents mesh cells 36. Themesh cells 36 of these segments are in one embodiment elongated in the longitudinal direction of thestents stent segments - The
first stent 12 may be divided into twosegments secondary branch conduits 34. Those skilled in the art will recognize that the first stent may comprise a variety of shapes such that it functions as described herein. Thefirst stent 12 may be expandable to a substantially cylindrical shape having a constant diameter along its length. Thefirst stent 12 may comprise a range of lengths depending on the specific desired location of placement. For example, the length of thefirst stent 12 will typically be between about 1 and about 4 centimeters as desired. - The
second stent 14 is preferably adapted to be deployed in close proximity to thefirst stent 12, and may also be divided into upper 26 and lower 28 segments. Thelower segment 28 of thesecond stent 14 typically has a tubular cross-sectional shape and has an expanded diameter which is substantially greater than the diameter of the principal conduit 32 (FIG. 3 ). Theupper segment 26 of thesecond stent 14 preferably comprises a larger diameter at its distal (upper) end 38 than at its proximal (lower)end 40. In one embodiment the upper segment of the second stent portion comprises a substantially conical shape. In an alternative embodiment, thesecond stent 14 may be tapered radially outward along its entire length in the distal direction. In either embodiment however, the expanded diameter of thedistal end 38 of thesecond stent 14 is preferably substantially larger than the expanded diameter of theproximal end 42 of thefirst stent 12. For example, thedistal end 38 of thesecond stent 14 may expand to a diameter that is at least about 105%, and preferably at least about 110%, and in some embodiments as much as 120% or more, of the diameter of theproximal end 42 of thefirst stent 12. Thesecond stent 14 may comprise a range of lengths depending on the specific desired location of placement. For example, thesecond stent 14 will typically be between 1 and 4 centimeters as desired. - In its expanded state, as shown in
FIG. 1 , theupper segment 26 of thesecond stent 14 typically hasmesh cells 36 whose width increases progressively, compared to that of the meshes of thelower segment 28, on the one hand in the longitudinal sense of thedual stent device 10, in the direction of thedistal end 38 of thesecond stent 14, and, on the other hand, in the transverse sense of thesecond stent 14, in the direction of a generatrix diametrically opposite that located in the continuation of thebridge 18. Alternatively stated, theupper segment 26 of thesecond stent 14 preferably comprises a mesh with multiplecellular shapes 36 which may have larger dimensions at adistal end 38 of thestent 14 than those at theproximal end 40 such that thesecond stent 14 expands to a substantially funnel shape. - In the embodiment shown, this increase in the width of the
mesh cells 36 results from an increase in the length of theedges 48 of themesh cells 36 disposed longitudinally, as well as an increase in the angle formed between two facingedges 48. - This
segment 26 thus may have a truncated shape with an axis which is oblique in relation to the longitudinal axis of thefirst stent 12 when expanded. This shape, for example, corresponds to the shape of the bifurcation shown in the area of the widened transitional zone 46 (FIG. 3 ) which separates the end of theprincipal conduit 32 from the ends of thesecondary conduits 34. In a preferred embodiment, thesecond stent 14 is placed in close proximity to thefirst stent 12. For example, thedistal end 38 of thesecond stent 14 is preferably placed within a distance of about 4 mm of thedistal end 42 of thefirst stent 12, more preferably this distance is less than about 2 mm, and most preferably the stents are placed within 1 mm of one another. - In the embodiment shown in
FIG. 1 , the distance between first andsecond stents bridge 18 between them.Bridges 18 may be provided to join the first andsecond stents lower segments stent bridges 18 may connect the adjacent ends of thesegments lower segment 24 of thefirst stent 12 in relation to theupper segment 26 of thesecond stent 14. - In addition, in other embodiments, the
bridges 18 could be integral with one of the connected segments and separately connected, such as by welding, to the other connected segment. For example, thebridge 18 which connects the first andsecond stents upper segment 26 of thesecond stent 14 and connected tolower segment 24 of thefirst segment 26. Alternatively, thebridge 18 could be integral with thelower segment 24 of thefirst stent 12 and connected to theupper segment 26 of thesecond stent 14. - In yet other embodiments, bridges 18 could be separate pieces of materials which are separately connected to
segments first stent 12 can be made from different pieces of material than thesecond stent 14. A tube from which thefirst stent 12 may be made (e.g. by laser cutting techniques) may comprise a smaller diameter than a tube from which thesecond stent 14 may be made. The respective tubes may or may not be made of the same material. Alternatively, the first and second stent may be formed from a single piece of material. - When the
segments second stent 14 are made from tubes of a smaller diameter than thesegments first stent 12, the radial force of thefirst stent segments second stent segments - Accordingly, bridges 18 can be made from one of these tubes, and thus be integral with
segments segments bridges 18 can be separate pieces of material. - In further embodiments, bridges 18 are omitted such that the individual segments are spaced as desired during installation and use. These individual segments are still delivered and implanted in the same core and sheath assembly.
- The
bridges 18 between two consecutive segments could be greater or smaller in number than six, and they could have a shape other than an omega shape, permitting their multidirectional elasticity, and in particular a V shape or W shape. - For example,
FIG. 8 shows an alternative embodiment of thestent system 10 with first 12 and second 14 stents shown in their unconstrained, expanded states. According to this embodiment, eachstent segments flexible bridges 18 connecting the first 12 andsecond stents 14 to one another. In this embodiment, the twoconsecutive segments second stents bridges 50. The curvedcentral part 52 of thesebridges 50 may have a multidirectional elasticity permitting the appropriate longitudinal orientation of the various segments in relation to one another. The advantage of thesebridges 50 is that they provide the stent with longitudinal continuity, which facilitates the passage of the stent system into a highly curved zone and which eliminates the need to reduce this curvature, (which may be dangerous in the cases of arteriosclerosis). - Thus, the
stent system 10 ofFIG. 8 can compriseseveral segments bifurcation 30. Theupper segment 26 of thesecond stent 14 could have an axis coincident with the longitudinal axis of the first stent, and not oblique in relation to this axis, if such is rendered necessary by the anatomy of the bifurcation which is to be treated. - Alternatively, the
lower segment 24 of thefirst stent 12 could itself have, in the expanded state, a widened shape similar to that of the second stent and corresponding to the shape of the widened connecting zone (increasing diameter in the proximal direction) by which, in certain bifurcations, thesecondary conduits 34 are connected to the widenedtransition zone 46. Thus, thelower segment 24 of thefirst stent 12, or the entirefirst stent 12 may have a first diameter at its distal end, and a second, larger diameter at its proximal end with a linear or progressive curve (flared) taper in between. According to this embodiment, thissegment 24 would thus have a shape corresponding to the shape of this widened connecting zone, and would ensure perfect support thereof. - One method of making a self-expanding stent is by appropriate cutting of a sheet of nickel/titanium alloy (for example, an alloy known by the name NITINOL may appropriately be used) into a basic shape, then rolling the resulting blank into a tubular form. The blank may be held in a cylindrical or frustoconical form by welding the opposing edges of this blank which come into proximity with each other. The stent(s) may also be formed by laser cutting from metal tube stock as is known in the art. Alternatively, a stent may be formed by selectively bending and forming a suitable cylindrical or noncylindrical tubular shape from a single or multiple wires, or thin strip of a suitable elastic material. Those skilled in the art will understand that many methods and materials are available for forming stents, only some of which are described herein.
- Some Nickel Titanium alloys are malleable at a temperature of the order of 10° C. but can recover a neutral shape at a temperature substantially corresponding to that of the human body.
FIG. 2 shows thestent system 10 disposed on a delivery catheter in a state of radial contraction. In one embodiment, a self-expanding stent may be contracted by cooling its constituent material of nickel-titanium or other shape-memory alloy to a temperature below its transformation temperature. The stent may later be expanded by exposing it to a temperature above the transformation temperature. In the present use, a shape-memory alloy with a transformation temperature at or below normal body temperature may be used. Those skilled in the art will recognize that a self-expanding stent made of a substantially elastic material may also be mechanically contracted from its expanded shape by applying a radial compressive force. The stent may then be allowed to expand under the influence of the material's own elasticity. Nickel titanium and other alloys such as such as Silver-Cadmium (Ag—Cd), Gold-Cadmium (Au—Cd) and Iron-Platinum (Fe3—Pt), to name but a few offer desirable superelastic qualities within a specific temperature range. - In one embodiment, the contraction of a stent may cause the mesh cell edges 48 to pivot in relation to the
transverse edges 49 of themesh cells 36 in such a way that themesh cells 36 have, in this state of contraction, a substantially rectangular shape. Those skilled in the art will recognize that other materials and methods of manufacturing may be employed to create a suitable self-expanding stent. - Alternatively, the stents used may be manually expandable by use of an inflatable dilatation balloon with or without perfusion as will be discussed further below. Many methods of making balloon-expandable stents are known to those skilled in the art. Balloon expandable stents may be made of a variety of bio-compatible materials having desirable mechanical properties such as stainless steel and titanium alloys. Balloon-expandable stents preferably have sufficient radial stiffness in their expanded state that they will hold the vessel wall at the desired diameter. In the case of a balloon-expandable
second stent 14, the balloon on which thesecond stent 14 is disposed may be specifically adapted to conform to the desired shape of thesecond stent 14. Specifically, such a balloon will preferably have a larger diameter at a distal end than at a proximal end. - The present discussion thus provides a pair of dissimilar stents permitting the treatment of a pathological condition in the area of a
bifurcation 30. This system has the many advantages indicated above, in particular those of ensuring a perfect support of the vessel wall and of being relatively simple to position. - For the sake of simplification, the segment which has, in the unconstrained expanded state, a cross section substantially greater than the cross section of one of the secondary conduits will be referred to hereinafter as the “secondary segment”, while the segment which has, in the expanded state, a truncated shape will be referred to hereinafter as the “truncated segment.”
- The secondary segment is intended to be introduced into the secondary conduit in the contracted state and when expanded will preferably bear against the wall of the conduit. This expansion not only makes it possible to treat a narrowing or a dissection situated in the area of the conduit, but also to ensure perfect immobilization of the apparatus in the conduit.
- In this position, the truncated segment bears against the wall of the conduit delimiting the widened transitional zone of the bifurcation, which it is able to support fully. A narrowing or a dissection occurring at this site can thus be treated by means of this apparatus, with uniform support of the vascular wall, and thus without risk of this wall being damaged.
- The two segments may be adapted to orient themselves suitably in relation to each other upon their expansion.
- Advantageously, at least the truncated segment may be covered by a membrane (for example, Dacron® or ePTFE) which gives it impermeability in a radial direction. This membrane makes it possible to trap between it and the wall of the conduit, the particles which may originate from the lesion being treated, such as arteriosclerotic particles or cellular agglomerates, thus avoiding the migration of these particles in the body. Thus, the apparatus can additionally permit treatment of an aneurysm by guiding the liquid through the bifurcation and thereby preventing stressing of the wall forming the aneurysm.
- The segments can be made from tubes of material of a different diameter, as discussed above, with the tube for the truncated segment having a larger diameter than the tube for the secondary segment. The tubes may be made from the same material. The use of tubes of different diameters can result in the truncated segment having a larger radial force, especially at larger diameters.
- The apparatus can comprise several secondary segments, placed one after the other, to ensure supplementary support of the wall of the secondary conduit and, if need be, to increase the anchoring force of the stent in the bifurcation. To this same end, the apparatus can comprise, on that side of the truncated segment directed toward the principal conduit, at least one radially expandable segment having, in the expanded state, a cross section which is substantially greater than the cross section of the principal conduit.
- These various supplementary segments may or may not be connected to each other and to the two aforementioned segments by means of flexible links, such as those indicated above.
- The flexible links can be integral with one of the segments and separately connected to the other segment, or the flexible links can be separate pieces of material separately connected to both segments, such as by welding.
- Preferably, the flexible link between two consecutive segments is made up of one or more bridges of material connecting the two adjacent ends of these two segments. Said bridge or bridges are advantageously made of the same material as that forming the segments.
- Each segment may have a meshwork structure, the meshes being elongated in the longitudinal direction of the stent, and each one having a substantially hexagonal shape; the meshes of the truncated segment may have a width which increases progressively in the longitudinal sense of the stent, in the direction of the end of this segment having the greatest cross section in the expanded state.
- This increase in the width of the meshes is the result of an increase in the length of the edges of the meshes disposed longitudinally and/or an increase in the angle formed between two facing edges of the same mesh.
- In addition, the truncated segment can have an axis not coincident with the longitudinal axis of the secondary segment, but oblique in relation to this axis, in order to be adapted optimally to the anatomy of the bifurcation which is to be treated. In this case, the widths of the meshes of the truncated segment also increase progressively, in the transverse sense of the stent, in the direction of a generatrix diametrically opposite that located in the continuation of the bridge connecting this segment to the adjacent segment.
- The apparatus can be made of a metal with shape memory, which becomes malleable, without elasticity, at a temperature markedly lower than that of the human body, in order to permit retraction of the apparatus upon itself, and to allow it to recover its neutral shape at a temperature substantially corresponding to that of the human body. This metal may be a nickel/titanium alloy known by the name NITINOL.
- The deployment catheter for positioning the stent or stents comprises means for positioning the stents and means for permitting the expansion of the stents when the latter are in place. These means can comprise a catheter having a removable sheath in which the stent is placed in the contracted state, when this stent is made of an elastic material, or a support core comprising an inflatable balloon on which the stent is placed, when this stent is made of a nonelastic material.
- In either case, this equipment comprises, according to the invention, means with which it is possible to identify and access, through the body of the patient, the longitudinal location of the truncated segment, so that the latter can be correctly positioned in the area of the widened zone of the bifurcation.
- In the case where the expansion of this same segment is not uniform in relation to the axis of the stent, the equipment additionally comprises means with which it is possible to identify, through the body of the patient, the angular orientation of the stent in relation to the bifurcation to be treated, so that the part of this segment having the greatest expansion can be placed in a suitable manner in relation to the bifurcation.
- Referring to
FIG. 9 , the stent system is generally deployed using an elongate flexiblestent deployment catheter 100. Although primarily described in the context of a multiple stent placement catheter without additional functional capabilities, the stent deployment catheter described herein can readily be modified to incorporate additional features such as an angioplasty balloon or balloons, with or without perfusion conduits, radiation or drug delivery capabilities, or stent sizing features, or any combination of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein. - The
elongate delivery catheter 100 generally includes aproximal end assembly 102, aproximal shaft section 110 including atubular body 111, adistal shaft section 120 including a distaltubular body 113, and adistal end assembly 107. Theproximal end 102 may include ahandpiece 140, having one or more hemostatic valves and/oraccess ports 106, such as for the infusion of drugs, contrast media or inflation media in a balloon expandable stent embodiment, as will be understood by those of skill in the art. In addition, aproximal guidewire port 172 may be provided on thehandpiece 140 in an over the wire embodiment (seeFIG. 9A ). Thehandpiece 140 disposed at the proximal end of thecatheter 100 may also be adapted to control deployment of the stents disposed on the catheter distal end 104 as will be discussed. - The length of the catheter depends upon the desired application. For example, lengths in the area of about 120 cm to about 140 cm are typical for use in coronary applications reached from a femoral artery access. Intracranial or lower carotid artery applications may call for a different catheter shaft length depending upon the vascular access site, as will be apparent to those of skill in the art.
- The
catheter 100 preferably has as small an outside diameter as possible to minimize the overall outside diameter (e.g. crossing profile) of the delivery catheter, while at the same time providing sufficient column strength to permit distal transluminal advancement of the taperedtip 122. Thecatheter 100 also preferably has sufficient column strength to allow an outer, axiallymoveable sheath 114 to be proximally retracted relative to thecentral core 112 in order to expose thestents 118. Thedelivery catheter 100 may be provided in either “over-the-wire” or “rapid exchange” types as will be discussed further below, and as will generally be understood by those skilled in the art. - In a catheter intended for peripheral vascular applications, the
outer sheath 114 will typically have an outside diameter within the range of from about 0.065 inches to about 0.092 inches. In coronary vascular applications, theouter sheath 114 may have an outside diameter with the range of from about 0.039 inches to about 0.065. Diameters outside of the preferred ranges may also be used, provided that the functional consequences of the diameter are acceptable for the intended purpose of the catheter. For example, the lower limit of the diameter for any portion ofcatheter 100 in a given application will be a function of the number of guidewire, pullwire or other functional lumen contained in the catheter, together with the acceptable minimum flow rate of dilatation fluid, contrast media or drugs to be delivered through the catheter and minimum contracted stent diameter. - The ability of the
catheter 100 to transmit torque may also be desirable, such as to avoid kinking upon rotation, to assist in steering, and in embodiments having an asymmetrical distal end on theproximal stent 14. Thecatheter 100 may be provided with any of a variety of torque and/or column strength enhancing structures, for example, axially extending stiffening wires, spiral wrapped support layers, or braided or woven reinforcement filaments which may be built into or layered on thecatheter 100. See, for example, U.S. Pat. No. 5,891,114 to Chien, et al., the disclosure of which is incorporated in its entirety herein by reference. - Referring to
FIG. 11D , there is illustrated a cross-sectional view through theproximal section 106 of thecatheter shaft 100 ofFIG. 9 . The embodiment shown inFIG. 11D represents a rapid exchange embodiment, and may comprise a single or multiple lumen extrusion or a hypotube including apull wire lumen 220. In an over-the-wire embodiment, theproximal section 106 additionally comprises a proximal extension of aguidewire lumen 132 and apull wire lumen 220. Theproximal tube 111 may also comprise an inflation lumen in a balloon catheter embodiment as will be understood by those skilled in the art. - At the
distal end 107, the catheter is adapted to retain and deploy one or more stents within a conduit of a human body. With reference toFIGS. 10A and 12 , thedistal end assembly 107 of thedelivery catheter 100 generally comprises aninner core 112, an axially moveableouter sheath 114, and optionally one or more inflatable balloons 116 (FIG. 12 ). Theinner core 112 is preferably a thin-walled tube at least partially designed to track over a guidewire, such as a standard 0.014 inch guidewire. Theouter sheath 114 preferably extends along at least adistal portion 120 of thecentral core 112 on which thestents 118 are preferably disposed. - The
outer sheath 114 may extend over a substantial length of thecatheter 100, or may comprise a relatively short length, distal to the proximalguidewire access port 172 as will be discussed. In general, theouter sheath 114 is between about 5 and about 25 cm long. - Referring to
FIG. 10 , the illustratedouter sheath 114 comprises aproximal section 115, adistal section 117 and atransition 119. Theproximal section 115 has an inside diameter which is slightly greater than the outside diameter of thetubular body 113. This enables theproximal section 115 to be slideably carried by thetubular body 113. Although theouter sheath 114 may be constructed having a uniform outside diameter throughout its length, the illustratedouter sheath 114 steps up in diameter at atransition 119. The inside diameter of thedistal section 117 ofouter sheath 114 is dimensioned to slideably capture the one or more stents as described elsewhere herein. In a stepped diameter embodiment such as that illustrated inFIG. 10 , the axial length of thedistal section 117 from thetransition 119 to the distal end is preferably sufficient to cover the stent or stents carried by thecatheter 100. Thus, thedistal section 117 in a two stent embodiment is generally at least about 3 cm and often within the range of from about 5 cm to about 10 cm in length. The axial length of theproximal section 115 can be varied considerably, depending upon the desired performance characteristics. For example,proximal section 115 may be as short as one or two centimeters, or up to as long as the entire length of the catheter. In the illustrated embodiment, theproximal section 115 is generally within the range of from about 5 cm to about 15 cm long. - The
outer sheath 114 andinner core 112 may be produced in accordance with any of a variety of known techniques for manufacturing rapid exchange or over the wire catheter bodies, such as by extrusion of appropriate biocompatible polymeric materials. Known materials for this application include high and medium density polyethylenes, polytetrafluoroethylene, nylons, PEBAX, PEEK, and a variety of others such as those disclosed in U.S. Pat. No. 5,499,973 to Saab, the disclosure of which is incorporated in its entirety herein by reference. Alternatively, at least a proximal portion or all of the length ofcentral core 112 and/orouter sheath 114 may comprise a metal or polymeric spring coil, solid walled hypodermic needle tubing, or braided reinforced wall, as is understood in the catheter and guidewire arts. - The
distal portion 117 ofouter sheath 114 is positioned concentrically over thestents 118 in order to hold them in their contracted state. As such, thedistal portion 117 of theouter sheath 114 is one form of a releasable restraint. The releasable restraint preferably comprises sufficient radial strength that it can resist deformation under the radial outward bias of a self-expanding stent. Thedistal portion 117 of theouter sheath 114 may comprise a variety of structures, including a spring coil, solid walled hypodermic needle tubing, banded, or braided reinforced wall to add radial strength as well as column strength to that portion of theouter sheath 114. Alternatively, the releasable restraint may comprise other elements such as water soluble adhesives or other materials such that once the stents are exposed to the fluid environment and/or the temperature of the blood stream, the restraint material will dissolve, thus releasing the self-expandable stents. A wide variety of biomaterials which are absorbable in an aqueous environment over different time intervals are known including a variety of compounds in the polyglycolic acid family, as will be understood by those of skill in the art. In yet another embodiment, a releasable restraint may comprise a plurality of longitudinal axial members disposed about the circumference of the stents. According to this embodiment anywhere from one to ten or more axial members may be used to provide a releasable restraint. The axial members may comprise cylindrical rods, flat or curved bars, or any other shape determined to be suitable. - In some situations, self expanding stents will tend to embed themselves in the inner wall of the
outer sheath 114 over time. As illustrated inFIGS. 9D and 10A , a plurality ofexpansion limiting bands 121 may be provided to surround sections of thestents sheath 114. Thebands 121 may be provided in any of a variety of numbers or positions depending upon the stent design.FIG. 10A illustrates the bands positioned at midpoints of each of the fourproximal stent sections 127 and each of the five distal stent sections. In an alternative embodiment, thebands 121 are positioned over the ends of adjacent stent sections. Thebands 121 may be made of stainless steel, or any other suitable metal or relatively non compliant polymer. Of course, many other structures may also be employed to prevent the self-expanding stents from embedding themselves in the plastic sheath. Such alternative structures may include a flexible coil, a braided tube, a solid-walled tube, or other restraint structures which will be apparent to those skilled in the art in view of the disclosure herein. - The inner surface of the
outer sheath 114, and/or the outer surface of thecentral core 112 may be further provided with a lubricious coating or lining such as Paralene, Teflon, silicone, polyimide-polytetrafluoroethylene composite materials or others known in the art and suitable depending upon the material of theouter sheath 114 and/orcentral core 112. -
FIG. 10B shows a distal portion ofsheath 114 received in anannular recess 230 in the distal tip. As shown, at least the distal portion of thesheath 114 may comprise a two layer construction having anouter tube 213 and an inner tube orcoating 212. The exterior surface of theouter tube 213 is preferably adapted to slide easily within the vessels to be treated, while the inner surface is generally adapted to have a low coefficient of static friction with respect to the stents, thus allowing the sheath to slide smoothly over the stents. Theouter tube 213 may, for example, be made of or coated with HDPE or PEBAX, and theinner tube 212 may, for example, be made of or coated with HDPE, PTFE, or FEP. In an embodiment in which the inner tube is made with a PTFE liner, however, thedistal end 214 of the lubricious inner layer ortube 212 is preferably spaced proximally from thedistal end 216 of theouter tube 213 by a distance within the range of from about 1 mm to about 3 mm. This helps prevent the stent from prematurely jumping distally out of the sheath during deployment due to the high lubricity of the PTFE surface. -
FIG. 10 illustrates one embodiment of a sheath retraction system. The system illustrated generally includes asheath pull wire 222, apull wire slot 224, asheath retraction band 226, and anouter sheath 114. Thesheath retraction band 226 may be a tubular element thermally or adhesively bonded or otherwise secured to a portion of theouter sheath 114. In the illustrated embodiment, theretraction band 226 comprises a section of stainless steel tubing having an outside diameter of about 0.055 inches, a wall thickness of about 0.0015 inches and an axial length of 0.060 inches. However, other dimensions may be readily utilized while still accomplishing the intended function. Thesheath retraction band 226 is positioned within thedistal portion 117 of theouter sheath 114, just distally of thediameter transition 119. Theretraction band 226 may be connected to the interior surface of theouter sheath 114 by heat fusing a pair ofbands 225 to the inside surface of the outer sheath at each end of the retraction band (seeFIG. 9E ). Alternatively, theretraction band 226 can be attached to the outer sheath by using adhesives, epoxies, or by mechanical methods such as crimping and swaging or a combination of these. In this manner, the pull force which would be required to proximally dislodge theretraction band 226 from theouter sheath 114 is greatly in excess of the proximal traction which will be applied to thepull wire 222 in clinical use. The distal end of thepull wire 222 is preferably welded, soldered, bonded, or otherwise secured to thesheath retraction band 226. Thepull wire 222 may alternatively be bonded directly to the outer sheath. - The
pull wire slot 224 is preferably of sufficient length to allow thesheath 114 to be fully retracted. Thus, thepull wire slot 224 is preferably at least as long as the distance from the distal end of thestent stop 218 to the distal end of thesheath 114 as shown inFIG. 10A . Slot lengths within the range of from about 1 cm to about 10 cm are presently contemplated for a two stent deployment system. With thesheath 114 in the distal position as shown, thepull wire slot 224 is preferably entirely covered by theproximal portion 115 of thesheath 114. Alternatively, in an embodiment in which the proximal extension ofsheath 114 extends the entire length of thecatheter 100, discussed above, it can be directly attached to thecontrol 150, in which case apull wire 222 and slot 224 as shown might not be used. - In yet another embodiment illustrated for example in
FIGS. 9B and 9C , apull wire lumen 220 may terminate sufficiently proximally from theretraction band 226 that a slot as shown may not be used. - The
pull wire 222 may comprise a variety of suitable profiles known to those skilled in the art, such as round, flat straight, or tapered. The diameter of a straightround pull wire 222 may be between about 0.008″ and about 0.018″ and in one embodiment is about 0.009″. In another embodiment, thepull wire 222 has a multiple tapered profile with diameters of 0.015″, 0.012″, and 0.009″ and a distal flat profile of 0.006″×0.012″. Thepull wire 222 may be made from any of a variety of suitable materials known to those skilled in the art, such as stainless steel or nitinol, and may be braided or single strand and may be coated with a variety of suitable materials such as Teflon, Paralene, etc. Thewire 222 has sufficient tensile strength to allow thesheath 114 to be retracted proximally relative to thecore 112. In some embodiments, thewire 222 may have sufficient column strength to allow thesheath 114 to be advanced distally relative to thecore 112 andstents distal stent 12 has been partially deployed, and the clinician determines that thestent 12 should be re-positioned, thesheath 114 may be advanced distally relative to thestent 12 thereby re-contracting and capturing that stent on the core. - In general, the tensile strength or compressibility of the
pull wire 222 may also be varied depending upon the desired mode of action of theouter sheath 114. For example, as an alternative to the embodiment described above, theouter sheath 114 may be distally advanced by axially distally advancing thepull wire 222, to release thestent 118. In a hybrid embodiment, theouter sheath 114 is split into a proximal portion and a distal portion. A pull wire is connected to the proximal portion, to allow proximal retraction to release the proximal stent. A push wire is attached to the distal portion, to allow distal advance, thereby releasing the distal stent. These construction details of thecatheter 100 and nature of thewire 222 may be varied to suit the needs of each of these embodiments, as will be apparent to those skilled in the art in view of the disclosure herein. - The
stents 118 are carried on thecentral support core 112, and are contracted radially thereon. By virtue of this contraction, thestents 118 have a cross section which is smaller than that of theconduits stents 118 are preferably disposed on a radially inwardly recesseddistal portion 129 of thecentral core 112 having a smaller diameter than the adjacent portions of thecore 112. SeeFIG. 12 . Thisrecess 129 is preferably defined distally by a distal abutment such as ashoulder 124 which may be in the form of a proximally facing surface on adistal tip 122.Distal tip 122 has an outer diameter smaller than that of thestents 118 when the stents are expanded, but greater than the diameter of thestents 118 when they are contracted. Thisabutment 124 consequently prevents distal advancement of thestents 118 from thecore 112 when thestents 118 are contracted. - Proximal movement of the
stents 118 relative to thecore 112 is prevented when the stents are in the radially contracted configuration by a proximal abutment surface such asannular shoulder 125. Thedistal abutment 124 andproximal abutment 125 may be in the form of annular end faces formed by the axial ends ofannular recess 129 in thecore 112, for receiving thecompressed stents 118. SeeFIG. 12 . In one embodiment, illustrated inFIG. 10A , theproximal abutment 125 is carried by astent stop 218.Stent stop 218 may be integral with or attached to thecentral core 112, and has an outside diameter such that it is in sliding contact with the inside surface ofouter sheath 114. Thecompressed stent 14 will thus not fit between thestop 218 and theouter sheath 114. - The
deployment device 100 typically has a softtapered tip 122 secured to the distal end ofinner core 112, and usually has aguidewire exit port 126 as is known in the art. The tapereddistal tip 122 facilitates insertion and atraumatic navigation of the vasculature for positioning thestent system 118 in the area of the bifurcation to be treated. Thedistal tip 122 can be made from any of a variety of polymeric materials well known in the medical device arts, such as polyethylene, nylon, PTFE, and PEBAX. In the embodiment shown inFIG. 10 , thedistal tip 122 comprises anannular recess 230 sized and adapted to allow a distal portion of theouter sheath 114 to reside therein such that the transition between the tip and the outer sheath comprises a smooth exterior surface. - The
distal tip 122 tapers in one embodiment from an outside diameter which is substantially the same as the outer diameter of theouter sheath 114 at theproximal end 128 of thetip 122 to an outside diameter at itsdistal end 130 of slightly larger than the outside diameter of a guidewire. The overall length of thedistal tip 122 in one embodiment of thedelivery catheter 100 is about 3 mm to about 12 mm, and in one embodiment the distal tip is about 8 mm long. The length and rate of taper of thedistal tip 122 can be varied depending upon the desired trackability and flexibility characteristics. Thetip 122 may taper in a linear, curved or any other manner known to be suitable. - With reference to
FIGS. 11B and 12 , a distal portion of thecentral core 112 preferably has a longitudinalaxial lumen 132 permitting slideable engagement of thecore 112 on aguidewire 170. Theguidewire lumen 132 preferably includes aproximal access port 172 and adistal access port 126 through which the guidewire may extend. Theproximal access port 172 may be located at a point along the length of thecatheter 100, as shown inFIGS. 11A and 11B , and discussed below (rapid exchange), or theproximal access port 172 may be located at theproximal end 102 of the catheter 100 (over the wire). In a rapid exchange embodiment, theproximal access port 172 is generally within about 25 cm of thedistal access port 126, and preferably is between about 20 cm and about 30 cm of thedistal access port 126. Theguidewire lumen 132 may be non-concentric with the catheter centerline for a substantial portion of the length of theguidewire lumen 132. -
FIGS. 11A and 11B illustrate a transition between aproximal shaft tube 111 and adistal shaft tube 113 including a proximalguidewire access port 172 and aguidewire lumen 132. Theguidewire lumen 132 may extend through a coextrusion, or may be a separate section of tubing which may be bonded, bound by a shrink wrap tubing, or otherwise held relative to theproximal shaft tube 111. - In the construction shown in cross-section in
FIG. 11B , aproximal shaft tube 111 having apull wire lumen 220 is joined to adistal shaft tube 113 having a continuation ofpull wire lumen 220 as well as aguidewire lumen 132. In the illustrated embodiment, theproximal shaft tube 111 extends distally into the proximal end ofconnector tubing 230. A mandrel is positioned within each lumen, and shrinktubing 236 is heated to bond the joint. An opening is subsequently formed in the shrink wrap to produceproximal access port 172 which provides access to theguidewire lumen 132. - In one embodiment, the
proximal shaft tube 111 comprises a stainless steel hypodermic needle tubing having an outside diameter of about 0.025″ and a wall thickness of about 0.003″. Thedistal end 123 of the hypotube is cut or ground into a tapered configuration. The axial length of the tapered zone may be varied widely, depending upon the desired flexibility characteristics of thecatheter 100. In general, the axial length of the taper is within the range of from about 1 cm to about 5 cm, and, in one embodiment, is about 2.5 cm. Tapering the distal end of the hypotube at the transition with the distal portion of the catheter provides a smooth transition of the flexibility characteristics along the length of the catheter, from a relatively less flexible proximal section to a relatively more flexible distal section as will be understood by those of skill in the art. - Referring to
FIG. 12 , aguidewire 170 is illustrated as positioned within theguidewire lumen 132. As can be appreciated by those of skill in the art, the diameter of theguidewire 170 is illustrated as slightly smaller (e.g., by about 0.001-0.003 inches) than the inside diameter of theguidewire lumen 132. Avoiding a tight fit between theguidewire 170 and inside diameter ofguidewire lumen 132 enhances the slideability of the catheter over theguidewire 170. In ultra small diameter catheter designs, it may be desirable to coat the outside surface of theguidewire 170 and/or the inside walls of theguidewire lumen 132 with a lubricous coating to minimize friction as thecatheter 100 is axially moved with respect to theguidewire 170. A variety of coatings may be utilized, such as Paralene, Teflon, silicone, polyimide-polytetrafluoroethylene composite materials or others known in the art and suitable depending upon the material of theguidewire 170 orcentral core 112. - As shown in
FIG. 12 , aninflation lumen 134 may also extend throughout the length of thecatheter 100 to place a proximal inflation port in fluid communication with one or moreinflatable balloons 116 carried by the distal end of the catheter. - The
inflatable balloon 116, if present, may be positioned beneath one or both stents, such asstent 14 as illustrated inFIG. 12 or proximally or distally of the stent, depending upon the desired clinical protocol. In one embodiment, as illustrated inFIG. 12 , the stent may be a self expandable stent which is initially released by proximal retraction by theouter sheath 114 as has been discussed. The balloon 16 is thereafter positioned in concentrically within the stent, such that it may be inflated without repositioning the catheter to enlarge and/or shape the stent. Post stent deployment dilatation may be desirable either to properly size and or shape the stent, or to compress material trapped behind the stent to increase the luminal diameter (e.g. angioplasty). In an alternate mode of practicing the invention, angioplasty is accomplished prior to deployment of the stent either by a balloon on thestent deployment catheter 100 or by a separate angioplasty balloon catheter (or rotational artherectomy, laser or other recanalization device). Thestent deployment catheter 100 is thereafter positioned within the dilated lesion, and the stent is thereafter deployed. Thus, balloon dilatation can be accomplished using either thedeployment catheter 100 or separate procedural catheter, and may be accomplished either prior to, simultaneously with, or following deployment of one or more stents at the treatment site. - As seen in
FIGS. 9 and 9B , the catheter also includes ahandpiece 140 at the proximal end of thecatheter 100. Thehandpiece 140 is adapted to be engaged by the clinician to navigate and deploy thestent system 118 as will be described below. Thehandpiece 140 preferably includes acontrol 150 adapted to control and indicate a degree of deployment of one or both stents. Thecontrol 150 is typically in mechanical communication with thesheath 114 such that proximal retraction of thecontrol 150 results in proximal retraction of thesheath 114. Those skilled in the art will recognize that distal motion, rotational movement of a rotatable wheel, or other motion ofvarious controls 150 may alternatively be employed to axially move such as distally advance or proximally retract thesheath 114 to expose the stents. - The illustrated
control 150 is preferably moveable from a first position to a second position for partial deployment of thefirst stent 12, and a third position for complete deployment of thefirst stent 12. A fourth and a fifth positions are also provided to accomplish partial and complete deployment of thesecond stent 14. Thecontrol 150 may includeindicia 160 adapted to indicate the amount of eachstent sheath 114 is retracted relative to thecore 112. Theindicia 160 may include dents, notches, or other markings to visually indicate the deployment progress. Thecontrol 150 may also or alternatively provide audible and/or tactile feedback using any of a variety of notches or other temporary catches to cause the slider to “click” into positions corresponding to partial and full deployment of thestents control 150 as desired. - The
catheter 100 may include a plurality of radiopaque markers 250 (seen best inFIGS. 2 , 10, and 10A) impressed on or otherwise bonded to it, containing a radiopaque compound as will be recognized by those skilled in the art. Suitable markers can be produced from a variety of materials, including platinum, gold, barium compounds, and tungsten/rhenium alloy. Some of themarkers 250A may have an annular shape and may extend around the entire periphery of thesheath 114. Theannular markers 250A may be situated, in the area of the distal end of thefirst stent 12, the distal end of thesecond stent 14, and in the area of the bridge 18 (FIG. 1 ) or space separating thestents fourth marker 252 may be situated at substantially the halfway point of the generatrix of the lower segment of thesecond stent 14 situated in the continuation of thebridge 18 and of the diametrically opposite generatrix.FIG. 2 shows amarker 252 with a diamond shape and a small thickness provided along theouter sheath 114 at a desirable position for determining the rotational position of the catheter within the bifurcation. Themarkers core 112, on thesheath 114, or directly on thestents bridge 18, and not on thesheath 114. - With reference to
FIGS. 10 and 10A , threemarkers 253 are shown disposed at a distal end of thesecond stent 14 and spaced at 120° relative to one another. Threemarkers 254 are also disposed at a proximal end of thefirst stent 12, and spaced at 120° relative to one another. Eachstent single marker 210 at its opposite end (e.g. thefirst stent 12 has asingle marker 210 at its distal end, and thesecond stent 14 has asingle marker 210 at its proximal end). Of course, other marker arrangements may be used as desired by the skilled artisan. - A
central marker 252 makes it possible to visualize, with the aid of a suitable radiography apparatus, the position of abridge 18 separating the twostents second stent 14 so that it can be correctly positioned in relation to the widenedzone 46. Theend markers 250A allow a specialist to ensure that thestents principal conduit 32 and the secondary/branch conduit 34. - A diamond-shaped
marker 252 as shown inFIG. 2 is, for its part, visible in a plan view or an edge view, depending on whether it is oriented perpendicular or parallel to the radius of the radiography apparatus. It thus makes it possible to identify the angular orientation of thestents bifurcation 30, so that the part of thesecond stent 14 having the greatest expansion can be placed in an appropriate manner in relation to the widenedtransition zone 46. - Methods of positioning and deploying a pair of dissimilar stents in an area of a bifurcation will now be discussed with reference to
FIGS. 3-6 and 13-17. Although portions of the following discussion refer to delivery of two dissimilar stent portions, those skilled in the art will recognize that a larger or smaller number of stents, and/or stents having similar expanded configurations may also be used while realizing certain aspects of the present invention. - A method of delivering a stent system as described above generally and illustrated in
FIGS. 13-17 includes locating thebifurcation 30 to be treated, providing asuitable delivery catheter 100, positioning thedistal portion 107 of a delivery catheter withstents first stent 12 in abranch vessel 34, observing and adjusting the position of thefirst stent 12 if necessary, then fully deploying thefirst stent 12. Thesecond stent 14 is partially deployed, and preferably the position is again observed such as by infusing contrast media through thepull wire lumen 220 under fluoroscopic visualization. The position of thesecond stent 14 may be adjusted if necessary, and finally thesecond stent 14 is fully deployed. Methods of navigating catheters through blood vessels or other fluid conduits within the human body are well known to those skilled in the art, and will therefore not be discussed herein. - The
delivery catheter 100 may be constructed according to any of the embodiments described above such that thestents outer sheath 114 along the delivery catheter, thereby selectively exposing thestent system 10. This may be accomplished by holding thesheath 114 fixed relative to the bifurcation, and selectively distally advancing thecentral core 112. Thus, the present invention contemplates deploying one or more stents by distally advancing the central core (inner sheath) rather than proximally retracting the outer sheath as a mode of stent deployment. The stent system may alternatively be deployed by holding the central core fixed relative to the bifurcation and selectively proximally retracting thesheath 114. The catheter may also be adapted to allow the sheath to be advanced distally, thereby re-contracting the partially deployed stents on thecentral core 112 to allow repositioning or removal. - In order to visualize the position of a partially-deployed stent with a suitable radiographic apparatus, a contrast media may be introduced through the catheter to the region of the stent placement. Many suitable contrast media are known to those skilled in the art. The contrast media may be introduced at any stage of the deployment of the
stent system 10. For example, a contrast media may be introduced after partially deploying thefirst stent 12, after fully deploying thefirst stent 12, after partially deploying thesecond stent 14, or after fully deploying thesecond stent 14. - The degree of deployment of the
stent system 10 is preferably made apparent by the indicators on thehandpiece 140 as described above. Thehandpiece 140 and outer sheath are preferably adapted such that a motion of a control on thehandpiece 140 results in proximal motion of theouter sheath 114 relative to thedistal tip 122 and thestents handpiece 140 andsheath 114 may also be adapted such that the sheath may be advanced distally relative to thestents stents core 112. This may be accomplished by providing apull wire 222 having a distal end 223 attached to a portion of theouter sheath 114, and a proximal end adapted to be attached to thehandpiece 140. Alternatively, thehandpiece 140 may be omitted, and theretraction wire 222 may be directly operated by the clinician. - In an alternative embodiment, indicated by
FIGS. 4-6 , the first and/orsecond stent stent sheath 114 is then progressively withdrawn, as is shown inFIGS. 5 and 6 , in order to permit the complete expansion of thestents - In a preferred embodiment, the
second stent 14 is placed in close proximity to thefirst stent 12. For example, thedistal end 38 of thesecond stent 14 may be placed within a distance of about 4 mm of theproximal end 42 of thefirst stent 12, more preferably this distance is less than about 2 mm, and most preferably the first andsecond stents second stents bridge 18 as discussed above. The axial flexibility of anybridge 18 will also affect the degree of mobility of one of the stents relative to the other. Thus, astent system 10 will preferably be chosen to best suit the particular bifurcation to be treated. - As mentioned above, the
stents second stent 14, the balloon 116 (FIG. 12A ) on which thesecond stent 14 is disposed may be specifically adapted to correspond to the particular shape of thesecond stent 14. Specifically, such a balloon will preferably have a larger diameter at a distal end than at a proximal end. - After complete expansion of the
stents delivery catheter 100 including thecore 112 and theguidewire 170 may be withdrawn from the conduits and the vasculature of the patient. Alternatively, additional stents may also be provided on a delivery catheter, which may also be positioned and deployed in one or both branches of the bifurcation. For example, after deploying thesecond stent 14 as shown inFIG. 6 or 17, thecatheter 100 and guidewire 170 may be retracted and re-positioned in the second branch vessel such that a third stent may be positioned and deployed therein. - Referring to
FIG. 18 , asecond branch stent 13 may be deployed in the second branch, such that both branch vessels in the bifurcation are fully stented. Thesecond branch stent 13 may be either a self expandable or balloon expandable stent such as those well known in the art and disclosed in part elsewhere herein. Thesecond branch stent 13 may be deployed before or after themain stent 14 and/orfirst branch stent 12. In one application of the invention, themain vessel stent 14 andfirst branch stent 12 are positioned as has been described herein. A stent deployment catheter (not illustrated) such as a balloon catheter or self expanding stent deployment catheter is transluminally advanced to the bifurcation, and advanced through themain vessel stent 14. The secondbranch vessel stent 13 may then be aligned in the second branch vessel, such that it abuts end to end, is spaced apart from, or overlaps with the distal end of themain branch stent 14. The secondbranch vessel stent 13 may then be deployed, and the deployment catheter removed. - As will be clear to those skilled in the art, the
stent system 10 andstent delivery system 100 described herein is useful in treating a number of pathological conditions commonly found in vascular systems and other fluid conduit systems of human patients. Treatment with the apparatus can include re-establishing the appropriate diameter of a bifurcation in cases of arteriosclerosis or internal cell proliferation, or in rectifying a localized or nonlocalized dissection in the wall of the conduit, or in re-creating a bifurcation of normal diameter while eliminating the aneurysmal pouch in cases of aneurysm. - One or more of the stents deployed in accordance with the present invention may be coated with or otherwise carry a drug to be eluted over time at the bifurcation site. Any of a variety of therapeutically useful agents may be used, including but not limited to, for example, agents for inhibiting restenosis, inhibiting platelet aggregation, or encouraging endothelialization. Some of the suitable agents may include smooth muscle cell proliferation inhibitors such as rapamycin, angiopeptin, and monoclonal antibodies capable of blocking smooth muscle cell proliferation; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, acetyl salicylic acid, and mesalamine, lipoxygenase inhibitors; calcium entry blockers such as verapamil, diltiazem and nifedipine; antineoplastic/antiproliferative/anti-mitotic agents such as paclitaxel, 5-fluorouracil, methotrexate, doxorubicin, daunorubicin, cyclosporine, cisplatin, vinblastine, vincristine, colchicine, epothilones, endostatin, angiostatin, Squalamine, and thymidine kinase inhibitors; L-arginine; antimicrobials such astriclosan, cephalosporins, aminoglycosides, and nitorfurantoin; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; nitric oxide (NO) donors such as lisidomine, molsidomine, NO-protein adducts, NO-polysaccharide adducts, polymeric or oligomeric NO adducts or chemical complexes; anti-coagulants such as D-Phe-Pro-Arg chloromethyl ketone, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, enoxaparin, hirudin, Warafin sodium, Dicumarol, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet factors; interleukins, interferons, and free radical scavengers; vascular cell growth promoters such as growth factors, growth factor receptor antagonists, transcriptional activators, and translational promotors; vascular cell growth inhibitors such as growth factor inhibitors (e.g., PDGF inhibitor—Trapidil), growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; Tyrosine kinase inhibitors, chymase inhibitors, e.g., Tranilast, ACE inhibitors, e.g., Enalapril, MMP inhibitors, (e.g., Ilomastat, Metastat), GP IIb/IIIa inhibitors (e.g., Intergrilin, abciximab), seratonin antagnonist, and 5-HT uptake inhibitors; cholesterol-lowering agents; vasodilating agents; and agents which interfere with endogeneus vascoactive mechanisms. Polynucleotide sequences may also function as anti-restenosis agents, such as p15, p16, p18, p19, p21, p27, p53, p57, Rb, nFkB and E2F decoys, thymidine kinase (“TK”) and combinations thereof and other agents useful for interfering with cell proliferation. The selection of an active agent can be made taking into account the desired clinical result and the nature of a particular patient's condition and contraindications. With or without the inclusion of a drug, any of the stents disclosed herein can be made from a bioabsorbable material.
- The
bifurcation 30 shown inFIG. 3 hasexcrescences 35 which create a narrowing in cross section, which impedes the flow of the liquid circulating in theconduits conduits transition zone 46. - As shown in
FIG. 7 , thestent system 10 can also be used to treat ananeurysm 242. Ananeurysm 242 is defined as a localized, pathological, blood-filled dilatation of a blood vessel caused by a disease or weakening of the vessel's wall. Thus it is desirable to provide a “substitute” vessel wall in an area of an aneurysm. For this purpose, the first orsecond stent film 240 which is substantially impermeable to the fluid circulating in theconduits stents vessel 32, thefilm 240 is trapped and held between the stent and the vessel wall. The stent then guides the liquid through thebifurcation 30 and consequently prevents stressing of the wall forming theaneurysm 242. - In some embodiments, each of the first (cylindrical)
stent 12 and second (tapered)stent 14 can be provided on its own individual delivery catheter. With reference toFIGS. 19-22 , embodiments of stent delivery systems for use in deploying a single stent for treatment of a pathology at a bifurcation are described below. -
FIGS. 19 and 20 illustrate a system configured to deploy a single stent having a substantially straight or cylindrical shape when in its expanded condition, for example, thestent 12 could be substantially the same as thecylindrical stent 12 of the above embodiments. The system generally includes anelongate delivery catheter 100 substantially as described above and having asingle stent 12 disposed on the distal end of the catheter. Thestent 12 is surrounded by aretractable sheath 114 having a plurality of radial restraints such as retainingbands 121. In the illustrated embodiment, five retainingbands 121 are provided to retain thestent 12 in a compressed condition. Alternatively, other numbers ofretention bands 121 may also be used. For example, one, two, three, four, or six ormore retention bands 121 may be used as desired for a particular stent. -
FIG. 20 shows the system ofFIG. 19 with a proximal detail of theouter sheath 114. The delivery system for use with thestraight stent 12 typically includes astent stop 218 with anannular shoulder 125 which the proximal end of thestent 12 will abut as thesheath 114 is retracted. As shown inFIG. 20 , thestent stop 218 will abut the proximal markers 254 (in an embodiment having such markers) as the sheath is retracted by a proximal force on thepull wire 222 which is attached to thesheath 114 at aretraction band 226. -
FIGS. 21 and 22 illustrate a system configured to deploy a single stent having a substantially conical or otherwise tapered shape when in its expanded condition. For example, theconical stent 14 may be the same or similar to themain branch stent 14 described above. The system ofFIG. 21 generally includes anelongate delivery catheter 100 substantially as described above and having a singleconical stent 14 disposed on the distal end of thecatheter 100. Thestent 14 is surrounded by aretractable sheath 114, which can include a radial retention structure such as a plurality of retainingbands 121. In the illustrated embodiment, four retainingbands 121 are provided to retain thestent 14 in a compressed condition and resist imprinting into thesheath 114. This number of retaining bands is particularly suited to theconical stent 14 according to one embodiment. Alternatively, other numbers ofretention bands 121 may also be used. For example, one, two, three, five, or six ormore retention bands 121 may be used as desired for a particular conical stent. -
FIG. 22 shows the system ofFIG. 21 with a proximal detail of theouter sheath 114. The delivery system for use with theconical stent 14 can include astent stop 218 with anannular shoulder 125 disposed within the outer sheath configured to provide an edge against which thestent 14 may abut as the sheath is retracted. Thestent stop 218 of the present embodiment illustrated inFIGS. 21 and 22 , comprises aslot 211 in which theproximal marker 210 of theconical stent 14 may rest. By contrast, thisslot 211 may be omitted in the embodiment illustrated inFIGS. 19 and 20 configured for use with a cylindrical stent, or if unnecessary in view of the particular conical stent design. - A delivery system adapted for use with a single stent will often be sized differently from the two-stent delivery system described above as will be apparent to those of skill in the art in view of the disclosure herein. For example, the axial length of the
stent receiving recess 129 in a single stent delivery catheter will often be somewhat shorter than a dual-stent catheter. In general, the axial length of thestent receiving recess 129 in a single, tapered stent system for use in a bifurcation of the coronary artery will be within the range of from about 8 mm to about 18 mm, and often within the range of from about 10 mm to about 13 mm. The tapered stent for use in coronary applications is generally at least 10 mm in axial length, for example, 10 mm, 11 mm, 12 mm, and 13 mm can be used. For coronary applications, the proximal expanded diameter is typically in the range of from about 3 mm, to about 6 mm, and often from about 3.5 mm to about 5.5 mm, and in one embodiment the proximal expanded diameter is about 4.5 mm. The distal expanded diameter is typically in the range of from about 5 mm, to about 8 mm, and often from about 5.5 mm to about 7.5 mm. In one embodiment of a tapered stent for use in coronary applications, the distal expanded diameter is about 6.5 mm. In one embodiment, theouter sheath 114 and the inner lumen of a single stent catheter can be about 11 mm shorter than the corresponding parts in a two-stent system. - A tapered stent for use in carotid or biliary applications generally has an axial length in the range of about 15 mm up to about 20 mm, and often between about 17 mm and about 19 mm. In one particular embodiment a tapered stent for use in carotid or biliary applications has an axial length of about 18 mm. For carotid or biliary applications, the proximal expanded diameter is typically in the range of from about 8 mm, to about 12 mm, and often from about 9 mm to about 11 mm, and in one embodiment the proximal expanded diameter is about 10 mm. The distal expanded diameter is typically in the range of from about 11 mm, to about 15 mm, and often from about 12 mm to about 14 mm. In one embodiment of a tapered stent for use in coronary applications, the distal expanded diameter is about 13 mm. In general, the distal expanded diameter is generally at least about 40% of the axial length, and often the distal expanded diameter is more than 50% of the axial length.
- The stent system described may be adapted as mentioned above to treat any of a number of bifurcations within a human patient. For example, bifurcations of both the left and right coronary arteries, the bifurcation of the circumflex artery, the carotid, femoral, iliac, popliteal, renal or other coronary bifurcations. Alternatively this apparatus may be used for nonvascular bifurcations, such as tracheal or biliary bifurcations, for example between the common bile and cystic ducts, or in the area of the bifurcation of the principal bile tract.
- Although certain preferred embodiments and examples have been described herein, it will be understood by those skilled in the art that the present inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the present inventive subject matter herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
Claims (18)
1. A deployment system for treating a bifurcation of a main vessel and a first and second branch vessels, comprising:
an elongate, flexible body, having an end and a downstream end;
a first stent carried by the downstream end of the body;
a drug, releasably carried by the stent;
a releasable restraint, for retaining the stent on the flexible body;
wherein the downstream end of the stent is larger in diameter than the upstream end of the stent in an unconstrained expanded configuration.
2. A deployment system as in claim 1 , further comprising a guidewire lumen extending axially through at least a portion of the flexible body.
3. A deployment system as in claim 2 , wherein the guidewire lumen has a proximal access port and a distal access port, and the proximal access port is positioned along the flexible body, spaced distally apart from the proximal end of the flexible body.
4. A deployment system as in claim 2 , wherein the guidewire lumen has a proximal access port and a distal access port, and the proximal access port is positioned at the proximal end of the flexible body.
5. A deployment system as in claim 1 , wherein the releasable restraint comprises an axially movable control element extending along the length of the flexible body.
6. A deployment system as in claim 1 , wherein the releasable restraint comprises a tubular sheath.
7. A deployment system as in claim 1 , wherein the releasable restraint comprises a pull wire.
8. A deployment system as in claim 1 , wherein the releasable restraint comprises a dissolvable media.
9. A deployment system as in claim 1 , wherein the releasable restraint comprises a plurality of expansion limiting bands.
10. A deployment system as in claim 1 , further comprising a second stent carried by the distal end of the flexible body.
11. A deployment system as in claim 10 , wherein the first and second stents have different expanded geometries from each other.
12. A deployment system as in claim 11 , wherein the second stent has a substantially cylindrical unconstrained expanded configuration.
13. A deployment system as in claim 10 , wherein the first and second stents are carried by the catheter such that release of the stents from the catheter causes the downstream end of the first stent and an upstream end of the second stent, as implanted, to be separated by a distance of no more than about 4 mm.
14. A deployment system as in claim 1 , wherein the expanded diameter of the first stent tapers radially outwardly in the distal direction.
15. A deployment system as in claim 1 , further comprising at least one marker on the downstream end.
16. A deployment system as in claim 1 , wherein the stent is configured for delivery to a bifurcation of the main coronary vessel such that the downstream end, when delivered, communicates with both the first and second branch vessels.
17. A deployment system as in claim 1 , wherein the stent is self expandable.
18. A deployment system as in claim 1 , wherein the stent has a single central lumen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/050,068 US20080161903A1 (en) | 2000-05-30 | 2008-03-17 | Noncylindrical Drug Eluting Stent for Treating Vascular Bifurcations |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/580,597 US6666883B1 (en) | 1996-06-06 | 2000-05-30 | Endoprosthesis for vascular bifurcation |
US10/225,484 US7238197B2 (en) | 2000-05-30 | 2002-08-20 | Endoprosthesis deployment system for treating vascular bifurcations |
US10/292,385 US8728143B2 (en) | 1996-06-06 | 2002-11-11 | Endoprosthesis deployment system for treating vascular bifurcations |
US10/435,096 US7344556B2 (en) | 2000-05-30 | 2003-05-09 | Noncylindrical drug eluting stent for treating vascular bifurcations |
US12/050,068 US20080161903A1 (en) | 2000-05-30 | 2008-03-17 | Noncylindrical Drug Eluting Stent for Treating Vascular Bifurcations |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/435,096 Division US7344556B2 (en) | 2000-05-30 | 2003-05-09 | Noncylindrical drug eluting stent for treating vascular bifurcations |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080161903A1 true US20080161903A1 (en) | 2008-07-03 |
Family
ID=32312141
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/292,385 Expired - Fee Related US8728143B2 (en) | 1996-06-06 | 2002-11-11 | Endoprosthesis deployment system for treating vascular bifurcations |
US10/435,096 Expired - Fee Related US7344556B2 (en) | 2000-05-30 | 2003-05-09 | Noncylindrical drug eluting stent for treating vascular bifurcations |
US12/050,068 Abandoned US20080161903A1 (en) | 2000-05-30 | 2008-03-17 | Noncylindrical Drug Eluting Stent for Treating Vascular Bifurcations |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/292,385 Expired - Fee Related US8728143B2 (en) | 1996-06-06 | 2002-11-11 | Endoprosthesis deployment system for treating vascular bifurcations |
US10/435,096 Expired - Fee Related US7344556B2 (en) | 2000-05-30 | 2003-05-09 | Noncylindrical drug eluting stent for treating vascular bifurcations |
Country Status (6)
Country | Link |
---|---|
US (3) | US8728143B2 (en) |
EP (1) | EP1560542A4 (en) |
JP (2) | JP5142239B2 (en) |
AU (2) | AU2003291416B2 (en) |
CA (1) | CA2505073A1 (en) |
WO (1) | WO2004043301A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7686845B2 (en) | 2000-05-30 | 2010-03-30 | Devax, Inc. | Noncylindrical stent deployment system for treating vascular bifurcations |
US20110054438A1 (en) * | 2009-08-28 | 2011-03-03 | Webster Mark W I | Stent delivery at a bifurcation, systems and methods |
KR101073035B1 (en) * | 2009-05-13 | 2011-10-12 | 연세대학교 산학협력단 | H Side-branch Stent |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8231667B2 (en) | 2002-11-08 | 2012-07-31 | Jacques Séguin | Endoprosthesis for vascular bifurcation |
US20120283821A1 (en) * | 2009-11-12 | 2012-11-08 | Industry-Academic Cooperation Foundation, Yonsei University | Stent for Protecting Bifurcated Blood Vessels in Bifurcation Lesion |
US8545514B2 (en) | 2008-04-11 | 2013-10-01 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8679142B2 (en) | 2008-02-22 | 2014-03-25 | Covidien Lp | Methods and apparatus for flow restoration |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US9101501B2 (en) | 1996-06-06 | 2015-08-11 | Biosensors International Group, Ltd. | Bifurcation stent and method of positioning in a body lumen |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
CN108836585A (en) * | 2018-05-28 | 2018-11-20 | 上海长海医院 | A kind of absorbable Y type carotid stents from Tu Mo branch of band |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
WO2023018892A1 (en) * | 2021-08-12 | 2023-02-16 | Tomasian Douglas A | Left coronary artery stent system, stent assembly and method therefore |
Families Citing this family (185)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835203B1 (en) * | 1996-11-04 | 2004-12-28 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6325826B1 (en) * | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
EP1723931B1 (en) * | 1996-11-04 | 2012-01-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus and method for deploying the same |
US7220275B2 (en) * | 1996-11-04 | 2007-05-22 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6599316B2 (en) * | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6099497A (en) * | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US8257425B2 (en) * | 1999-01-13 | 2012-09-04 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
EP1152711B1 (en) * | 1999-01-27 | 2005-07-06 | Boston Scientific Limited | Bifurcation stent delivery system |
DE10010073B4 (en) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring for implantable heart valve prostheses |
DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
US20030139803A1 (en) * | 2000-05-30 | 2003-07-24 | Jacques Sequin | Method of stenting a vessel with stent lumenal diameter increasing distally |
WO2002067653A2 (en) | 2001-02-26 | 2002-09-06 | Scimed Life Systems, Inc. | Bifurcated stent and delivery system |
EP1258230A3 (en) | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US20040176837A1 (en) * | 2001-05-17 | 2004-09-09 | Atladottir Svava Maria | Self-expanding stent and catheter assembly and method for treating bifurcations |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US8080048B2 (en) * | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7270668B2 (en) * | 2001-12-03 | 2007-09-18 | Xtent, Inc. | Apparatus and methods for delivering coiled prostheses |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US7264631B2 (en) * | 2002-09-16 | 2007-09-04 | Scimed Life Systems, Inc. | Devices and methods for AAA management |
KR100893070B1 (en) * | 2002-09-19 | 2009-04-17 | 엘지전자 주식회사 | Method and apparatus for providing and receiving multicast service in a radio communication system |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US7604660B2 (en) | 2003-05-01 | 2009-10-20 | Merit Medical Systems, Inc. | Bifurcated medical appliance delivery apparatus and method |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
EP1641671B1 (en) * | 2003-06-27 | 2015-06-24 | Portaclave LLP | Portable fuel cartridge for fuel cells |
CN1470294A (en) * | 2003-07-07 | 2004-01-28 | �й���ѧԺ����Ӧ�û�ѧ�о��� | Biodegradable common bile duct built-in carriage and its making method |
US6840569B1 (en) * | 2003-07-22 | 2005-01-11 | Arthur Donald Leigh | Caravan |
US8298280B2 (en) * | 2003-08-21 | 2012-10-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US7175654B2 (en) * | 2003-10-16 | 2007-02-13 | Cordis Corporation | Stent design having stent segments which uncouple upon deployment |
US20050085897A1 (en) * | 2003-10-17 | 2005-04-21 | Craig Bonsignore | Stent design having independent stent segments which uncouple upon deployment |
US20050096725A1 (en) | 2003-10-29 | 2005-05-05 | Pomeranz Mark L. | Expandable stent having removable slat members |
US9078780B2 (en) * | 2003-11-08 | 2015-07-14 | Cook Medical Technologies Llc | Balloon flareable branch vessel prosthesis and method |
US7090694B1 (en) * | 2003-11-19 | 2006-08-15 | Advanced Cardiovascular Systems, Inc. | Portal design for stent for treating bifurcated vessels |
US20050125050A1 (en) * | 2003-12-04 | 2005-06-09 | Wilson Cook Medical Incorporated | Biliary stent introducer system |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7572228B2 (en) | 2004-01-13 | 2009-08-11 | Remon Medical Technologies Ltd | Devices for fixing a sensor in a lumen |
US8998973B2 (en) * | 2004-03-02 | 2015-04-07 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
US7901447B2 (en) * | 2004-12-29 | 2011-03-08 | Boston Scientific Scimed, Inc. | Medical devices including a metallic film and at least one filament |
US20050197687A1 (en) * | 2004-03-02 | 2005-09-08 | Masoud Molaei | Medical devices including metallic films and methods for making same |
US20060142838A1 (en) * | 2004-12-29 | 2006-06-29 | Masoud Molaei | Medical devices including metallic films and methods for loading and deploying same |
US8591568B2 (en) * | 2004-03-02 | 2013-11-26 | Boston Scientific Scimed, Inc. | Medical devices including metallic films and methods for making same |
US8992592B2 (en) * | 2004-12-29 | 2015-03-31 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
US8632580B2 (en) * | 2004-12-29 | 2014-01-21 | Boston Scientific Scimed, Inc. | Flexible medical devices including metallic films |
US8007528B2 (en) * | 2004-03-17 | 2011-08-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050273150A1 (en) * | 2004-03-31 | 2005-12-08 | Howell Douglas D | Stent introducer system |
WO2005122959A2 (en) | 2004-06-08 | 2005-12-29 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US7635510B2 (en) * | 2004-07-07 | 2009-12-22 | Boston Scientific Scimed, Inc. | High performance balloon catheter/component |
US20060089702A1 (en) * | 2004-10-27 | 2006-04-27 | Medtronic Vascular, Inc. | Sleeve to protect ratcheting stent from interference with guide catheter |
US7147659B2 (en) * | 2004-10-28 | 2006-12-12 | Cordis Neurovascular, Inc. | Expandable stent having a dissolvable portion |
US7156871B2 (en) * | 2004-10-28 | 2007-01-02 | Cordis Neurovascular, Inc. | Expandable stent having a stabilized portion |
US20060122522A1 (en) * | 2004-12-03 | 2006-06-08 | Abhi Chavan | Devices and methods for positioning and anchoring implantable sensor devices |
US9427340B2 (en) * | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US10390714B2 (en) * | 2005-01-12 | 2019-08-27 | Remon Medical Technologies, Ltd. | Devices for fixing a sensor in a lumen |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
FR2881946B1 (en) * | 2005-02-17 | 2008-01-04 | Jacques Seguin | DEVICE FOR THE TREATMENT OF BODILY CONDUIT AT BIFURCATION LEVEL |
US8652193B2 (en) | 2005-05-09 | 2014-02-18 | Angiomed Gmbh & Co. Medizintechnik Kg | Implant delivery device |
US7854760B2 (en) * | 2005-05-16 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
US7862601B2 (en) * | 2005-05-23 | 2011-01-04 | Incept Llc | Apparatus and methods for delivering a stent into an ostium |
US9034025B2 (en) | 2005-05-23 | 2015-05-19 | Ostial Corporation | Balloon catheters and methods for use |
US8317855B2 (en) * | 2005-05-26 | 2012-11-27 | Boston Scientific Scimed, Inc. | Crimpable and expandable side branch cell |
US8480728B2 (en) * | 2005-05-26 | 2013-07-09 | Boston Scientific Scimed, Inc. | Stent side branch deployment initiation geometry |
US20060271161A1 (en) * | 2005-05-26 | 2006-11-30 | Boston Scientific Scimed, Inc. | Selective treatment of stent side branch petals |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US7320702B2 (en) * | 2005-06-08 | 2008-01-22 | Xtent, Inc. | Apparatus and methods for deployment of multiple custom-length prostheses (III) |
GB0512321D0 (en) * | 2005-06-16 | 2005-07-27 | Angiomed Ag | Catheter device double swaging |
KR100644194B1 (en) * | 2005-08-02 | 2006-11-10 | 휴메드 주식회사 | Device for treatment of an aortic aneurysm |
US8038706B2 (en) * | 2005-09-08 | 2011-10-18 | Boston Scientific Scimed, Inc. | Crown stent assembly |
US7731741B2 (en) | 2005-09-08 | 2010-06-08 | Boston Scientific Scimed, Inc. | Inflatable bifurcation stent |
US8043366B2 (en) * | 2005-09-08 | 2011-10-25 | Boston Scientific Scimed, Inc. | Overlapping stent |
US20070061003A1 (en) * | 2005-09-15 | 2007-03-15 | Cappella, Inc. | Segmented ostial protection device |
US20070088428A1 (en) * | 2005-09-15 | 2007-04-19 | Cappella, Inc. | Intraluminal device with asymmetric cap portion |
DE102005051849B4 (en) | 2005-10-28 | 2010-01-21 | JenaValve Technology Inc., Wilmington | Device for implantation and attachment of heart valve prostheses |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
US20070112418A1 (en) | 2005-11-14 | 2007-05-17 | Boston Scientific Scimed, Inc. | Stent with spiral side-branch support designs |
US8435284B2 (en) * | 2005-12-14 | 2013-05-07 | Boston Scientific Scimed, Inc. | Telescoping bifurcated stent |
US8343211B2 (en) * | 2005-12-14 | 2013-01-01 | Boston Scientific Scimed, Inc. | Connectors for bifurcated stent |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US8060214B2 (en) | 2006-01-05 | 2011-11-15 | Cardiac Pacemakers, Inc. | Implantable medical device with inductive coil configurable for mechanical fixation |
US20070208419A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcation stent with uniform side branch projection |
US7833264B2 (en) * | 2006-03-06 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20070208415A1 (en) * | 2006-03-06 | 2007-09-06 | Kevin Grotheim | Bifurcated stent with controlled drug delivery |
US20070208411A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent with surface area gradient |
US8298278B2 (en) * | 2006-03-07 | 2012-10-30 | Boston Scientific Scimed, Inc. | Bifurcated stent with improvement securement |
US20070219617A1 (en) * | 2006-03-17 | 2007-09-20 | Sean Saint | Handle for Long Self Expanding Stent |
WO2007109621A2 (en) | 2006-03-20 | 2007-09-27 | Xtent, Inc. | Apparatus and methods for deployment of linked prosthetic segments |
US20070233233A1 (en) * | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc | Tethered expansion columns for controlled stent expansion |
EP2051673A2 (en) | 2006-06-23 | 2009-04-29 | Boston Scientific Limited | Bifurcated stent with twisted hinges |
US8029558B2 (en) * | 2006-07-07 | 2011-10-04 | Abbott Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US8834554B2 (en) * | 2006-08-22 | 2014-09-16 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8882826B2 (en) * | 2006-08-22 | 2014-11-11 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8216267B2 (en) * | 2006-09-12 | 2012-07-10 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US8676349B2 (en) | 2006-09-15 | 2014-03-18 | Cardiac Pacemakers, Inc. | Mechanism for releasably engaging an implantable medical device for implantation |
ES2369203T3 (en) | 2006-09-15 | 2011-11-28 | Cardiac Pacemakers, Inc. | ANCHORAGE FOR AN IMPLANTABLE MEDICAL DEVICE. |
US20080081829A1 (en) * | 2006-09-28 | 2008-04-03 | Med Institute, Inc | Medical Device Including an Anesthetic and Method of Preparation Thereof |
US20080082038A1 (en) * | 2006-09-28 | 2008-04-03 | Vance Products Incorporated, D/B/A/ Cook Urological Incorporated | Medical Device including a Bioactive in a Non-ionic and an Ionic Form and Methods of Preparation Thereof |
US7951191B2 (en) | 2006-10-10 | 2011-05-31 | Boston Scientific Scimed, Inc. | Bifurcated stent with entire circumferential petal |
US8206429B2 (en) | 2006-11-02 | 2012-06-26 | Boston Scientific Scimed, Inc. | Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same |
US7842082B2 (en) | 2006-11-16 | 2010-11-30 | Boston Scientific Scimed, Inc. | Bifurcated stent |
FR2911063B1 (en) | 2007-01-09 | 2009-03-20 | Stentys S A S Soc Par Actions | RUPTIBLE BRIDGE STRUCTURE FOR STENT, AND STENT INCLUDING SUCH BRIDGE STRUCTURES. |
US7959668B2 (en) | 2007-01-16 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8118861B2 (en) * | 2007-03-28 | 2012-02-21 | Boston Scientific Scimed, Inc. | Bifurcation stent and balloon assemblies |
US8647376B2 (en) * | 2007-03-30 | 2014-02-11 | Boston Scientific Scimed, Inc. | Balloon fold design for deployment of bifurcated stent petal architecture |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US9295551B2 (en) | 2007-04-13 | 2016-03-29 | Jenavalve Technology Gmbh | Methods of implanting an endoprosthesis |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8204599B2 (en) | 2007-05-02 | 2012-06-19 | Cardiac Pacemakers, Inc. | System for anchoring an implantable sensor in a vessel |
US20080283066A1 (en) * | 2007-05-17 | 2008-11-20 | Cardiac Pacemakers, Inc. | Delivery device for implantable sensors |
US7634318B2 (en) | 2007-06-14 | 2009-12-15 | Cardiac Pacemakers, Inc. | Multi-element acoustic recharging system |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US7833266B2 (en) | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US10022250B2 (en) * | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US8277501B2 (en) | 2007-12-21 | 2012-10-02 | Boston Scientific Scimed, Inc. | Bi-stable bifurcated stent petal geometry |
JP5504173B2 (en) | 2007-12-31 | 2014-05-28 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Catheter assembly for vascular bifurcation treatment |
WO2009089297A2 (en) * | 2008-01-07 | 2009-07-16 | Intersect Partners, Llc | Novel enhanced ptna rapid exchange type of catheter system |
US8465540B2 (en) | 2008-02-26 | 2013-06-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US8398704B2 (en) | 2008-02-26 | 2013-03-19 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US8317858B2 (en) | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
EP2296536A1 (en) | 2008-07-15 | 2011-03-23 | Cardiac Pacemakers, Inc. | Implant assist apparatus for acoustically enabled implantable medical device |
US9005274B2 (en) * | 2008-08-04 | 2015-04-14 | Stentys Sas | Method for treating a body lumen |
US20100049307A1 (en) * | 2008-08-25 | 2010-02-25 | Aga Medical Corporation | Stent graft having extended landing area and method for using the same |
US8597454B2 (en) | 2008-09-23 | 2013-12-03 | Cook Medical Technologies Llc | Catheter tip assembly |
CN102215780B (en) | 2008-09-25 | 2015-10-14 | 高级分支系统股份有限公司 | Part crimped stent |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US8769796B2 (en) | 2008-09-25 | 2014-07-08 | Advanced Bifurcation Systems, Inc. | Selective stent crimping |
GB0823716D0 (en) * | 2008-12-31 | 2009-02-04 | Angiomed Ag | Stent delivery device with rolling stent retaining sheath |
US8694129B2 (en) | 2009-02-13 | 2014-04-08 | Cardiac Pacemakers, Inc. | Deployable sensor platform on the lead system of an implantable device |
US20100292779A1 (en) | 2009-05-15 | 2010-11-18 | Helmut Straubinger | Device for compressing a stent and a system as well as a method for loading a stent into a medical delivery system |
EP2496189A4 (en) * | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
CN103037816B (en) | 2010-03-24 | 2018-12-28 | 高级分支系统股份有限公司 | System and method for handling furcation |
WO2011119883A1 (en) | 2010-03-24 | 2011-09-29 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
AU2011232360B2 (en) | 2010-03-24 | 2015-10-08 | Advanced Bifurcation Systems Inc. | Methods and systems for treating a bifurcation with provisional side branch stenting |
US11278406B2 (en) | 2010-05-20 | 2022-03-22 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
US9301864B2 (en) | 2010-06-08 | 2016-04-05 | Veniti, Inc. | Bi-directional stent delivery system |
US8864811B2 (en) | 2010-06-08 | 2014-10-21 | Veniti, Inc. | Bi-directional stent delivery system |
US9233014B2 (en) | 2010-09-24 | 2016-01-12 | Veniti, Inc. | Stent with support braces |
EP2624791B1 (en) * | 2010-10-08 | 2017-06-21 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design |
WO2012109382A2 (en) | 2011-02-08 | 2012-08-16 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use |
EP2672932B1 (en) | 2011-02-08 | 2018-09-19 | Advanced Bifurcation Systems, Inc. | System for treating a bifurcation with a fully crimped stent |
EP2706926B1 (en) | 2011-05-11 | 2016-11-30 | Covidien LP | Vascular remodeling device |
EP2768428A4 (en) | 2011-10-21 | 2015-05-06 | Merit Medical Systems Inc | Devices and methods for stenting an airway |
JP6005168B2 (en) | 2011-10-21 | 2016-10-12 | イエナバルブ テクノロジー インク | Catheter system for introducing an expandable heart valve stent into a patient's body, insertion system equipped with a catheter system, and medical device for treating heart valve defects |
US9161855B2 (en) | 2011-10-24 | 2015-10-20 | Ethicon, Inc. | Tissue supporting device and method |
AU2012200735C1 (en) * | 2012-02-08 | 2013-01-24 | Cook Medical Technologies Llc | Orientation markers for endovascular delivery system |
EP2849678B1 (en) | 2012-05-16 | 2022-08-10 | JenaValve Technology, Inc. | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect |
US9387106B2 (en) * | 2013-02-28 | 2016-07-12 | Medtronic Vascular, Inc. | Medical device delivery systems and methods of use thereof |
US10130501B2 (en) | 2013-03-12 | 2018-11-20 | Cook Medical Technologies Llc | Delivery device with an extension sheath and methods of using the same |
US9439793B2 (en) | 2013-03-12 | 2016-09-13 | Cook Medical Technologies Llc | Extension for iliac branch delivery device and methods of using the same |
WO2015028209A1 (en) | 2013-08-30 | 2015-03-05 | Jenavalve Technology Gmbh | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
EP3047819A4 (en) * | 2013-09-16 | 2017-04-12 | Industry-Academic Cooperation Foundation, Yonsei University | Self-expanding stent transfer device |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US9757574B2 (en) | 2015-05-11 | 2017-09-12 | Rainbow Medical Ltd. | Dual chamber transvenous pacemaker |
JP6960110B2 (en) * | 2015-05-21 | 2021-11-05 | ニプロ株式会社 | Stent |
JP6676424B2 (en) * | 2016-03-16 | 2020-04-08 | 日本ライフライン株式会社 | Treatment equipment |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
US10940030B2 (en) * | 2017-03-10 | 2021-03-09 | Serenity Medical, Inc. | Method and system for delivering a self-expanding stent to the venous sinuses |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3805301A (en) * | 1972-07-28 | 1974-04-23 | Meadox Medicals Inc | Tubular grafts having indicia thereon |
US3945052A (en) * | 1972-05-01 | 1976-03-23 | Meadox Medicals, Inc. | Synthetic vascular graft and method for manufacturing the same |
US4562596A (en) * | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4733065A (en) * | 1984-06-27 | 1988-03-22 | Canon Kabushiki Kaisha | Optical head device with diffraction grating for separating a light beam incident on an optical recording medium from a light beam reflected therefrom |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4806062A (en) * | 1987-10-29 | 1989-02-21 | Maxon Industries, Inc. | Stowable lift for freight vehicles |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5192297A (en) * | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5211663A (en) * | 1991-06-24 | 1993-05-18 | Smith & Nephew Richards, Inc. | Passivation methods for metallic medical implants |
US5211658A (en) * | 1991-11-05 | 1993-05-18 | New England Deaconess Hospital Corporation | Method and device for performing endovascular repair of aneurysms |
US5282824A (en) * | 1990-10-09 | 1994-02-01 | Cook, Incorporated | Percutaneous stent assembly |
US5387235A (en) * | 1991-10-25 | 1995-02-07 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5405378A (en) * | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5499973A (en) * | 1994-09-08 | 1996-03-19 | Saab; Mark A. | Variable stiffness balloon dilatation catheters |
US5510077A (en) * | 1992-03-19 | 1996-04-23 | Dinh; Thomas Q. | Method of making an intraluminal stent |
US5514178A (en) * | 1993-06-24 | 1996-05-07 | Synthelabo | Prosthesis for bodily canal |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5591228A (en) * | 1995-05-09 | 1997-01-07 | Edoga; John K. | Methods for treating abdominal aortic aneurysms |
US5609605A (en) * | 1994-08-25 | 1997-03-11 | Ethicon, Inc. | Combination arterial stent |
US5609627A (en) * | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5632762A (en) * | 1995-11-09 | 1997-05-27 | Hemodynamics, Inc. | Ostial stent balloon |
US5632771A (en) * | 1993-07-23 | 1997-05-27 | Cook Incorporated | Flexible stent having a pattern formed from a sheet of material |
US5632772A (en) * | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5632763A (en) * | 1995-01-19 | 1997-05-27 | Cordis Corporation | Bifurcated stent and method for implanting same |
WO1997046174A1 (en) * | 1996-06-06 | 1997-12-11 | Jacques Seguin | Vascular bifurcation endoprosthesis |
US5707376A (en) * | 1992-08-06 | 1998-01-13 | William Cook Europe A/S | Stent introducer and method of use |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5720776A (en) * | 1991-10-25 | 1998-02-24 | Cook Incorporated | Barb and expandable transluminal graft prosthesis for repair of aneurysm |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5749825A (en) * | 1996-09-18 | 1998-05-12 | Isostent, Inc. | Means method for treatment of stenosed arterial bifurcations |
US5749890A (en) * | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
US5755769A (en) * | 1992-03-12 | 1998-05-26 | Laboratoire Perouse Implant | Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof |
US5755771A (en) * | 1994-11-03 | 1998-05-26 | Divysio Solutions Ulc | Expandable stent and method of delivery of same |
US5873904A (en) * | 1995-06-07 | 1999-02-23 | Cook Incorporated | Silver implantable medical device |
US5891114A (en) * | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US5893887A (en) * | 1997-10-14 | 1999-04-13 | Iowa-India Investments Company Limited | Stent for positioning at junction of bifurcated blood vessel and method of making |
US5897588A (en) * | 1997-03-14 | 1999-04-27 | Hull; Cheryl C. | Coronary stent and method of fabricating same |
US5904713A (en) * | 1997-07-14 | 1999-05-18 | Datascope Investment Corp. | Invertible bifurcated stent/graft and method of deployment |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US6019778A (en) * | 1998-03-13 | 2000-02-01 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6030415A (en) * | 1997-01-29 | 2000-02-29 | Endovascular Technologies, Inc. | Bell-bottom modular stent-graft |
US6042606A (en) * | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US6042588A (en) * | 1998-03-03 | 2000-03-28 | Scimed Life Systems, Inc | Stent delivery system |
US6059813A (en) * | 1998-11-06 | 2000-05-09 | Scimed Life Systems, Inc. | Rolling membrane stent delivery system |
US6063113A (en) * | 1995-06-13 | 2000-05-16 | William Cook Europe Aps | Device for implantation in a vessel or hollow organ lumen |
US6165195A (en) * | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6179858B1 (en) * | 1998-05-12 | 2001-01-30 | Massachusetts Institute Of Technology | Stent expansion and apposition sensing |
US6183509B1 (en) * | 1995-05-04 | 2001-02-06 | Alain Dibie | Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device |
US6197049B1 (en) * | 1999-02-17 | 2001-03-06 | Endologix, Inc. | Articulating bifurcation graft |
US6203568B1 (en) * | 1996-04-05 | 2001-03-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US6210429B1 (en) * | 1996-11-04 | 2001-04-03 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6210431B1 (en) * | 1999-12-10 | 2001-04-03 | John A. Power | Ostial bifurcation lesion stenting catheter |
US6221090B1 (en) * | 1997-08-13 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Stent delivery assembly |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US6340368B1 (en) * | 1998-10-23 | 2002-01-22 | Medtronic Inc. | Implantable device with radiopaque ends |
US20020016597A1 (en) * | 2000-08-02 | 2002-02-07 | Dwyer Clifford J. | Delivery apparatus for a self-expanding stent |
US6346118B1 (en) * | 1983-12-09 | 2002-02-12 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
US20020028984A1 (en) * | 2000-09-01 | 2002-03-07 | Asahi Kogaku Kogyo Kabushiki Kaisha Tokyo, Japan | Flexible tube for an endoscope and electronic endoscope equipped with the flexible tube |
US6358556B1 (en) * | 1995-04-19 | 2002-03-19 | Boston Scientific Corporation | Drug release stent coating |
US20020035389A1 (en) * | 1996-05-03 | 2002-03-21 | Jacob Richter | Bifurcated stent with improved side branch aperture and method of making same |
US6361544B1 (en) * | 1997-08-13 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6361557B1 (en) * | 1999-02-05 | 2002-03-26 | Medtronic Ave, Inc. | Staplebutton radiopaque marker |
US6375676B1 (en) * | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6503271B2 (en) * | 1998-01-09 | 2003-01-07 | Cordis Corporation | Intravascular device with improved radiopacity |
US6514281B1 (en) * | 1998-09-04 | 2003-02-04 | Scimed Life Systems, Inc. | System for delivering bifurcation stents |
US6520988B1 (en) * | 1997-09-24 | 2003-02-18 | Medtronic Ave, Inc. | Endolumenal prosthesis and method of use in bifurcation regions of body lumens |
US6527789B1 (en) * | 1991-01-28 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US6533810B2 (en) * | 1995-11-27 | 2003-03-18 | Schneider (Europe) Ag | Conical stent |
US20040006381A1 (en) * | 2000-05-30 | 2004-01-08 | Jacques Sequin | Noncylindrical drug eluting stent for treating vascular bifurcations |
US6692483B2 (en) * | 1996-11-04 | 2004-02-17 | Advanced Stent Technologies, Inc. | Catheter with attached flexible side sheath |
US6695875B2 (en) * | 2000-03-14 | 2004-02-24 | Cook Incorporated | Endovascular stent graft |
US6699274B2 (en) * | 2001-01-22 | 2004-03-02 | Scimed Life Systems, Inc. | Stent delivery system and method of manufacturing same |
US6702846B2 (en) * | 1996-04-09 | 2004-03-09 | Endocare, Inc. | Urological stent therapy system and method |
US6706062B2 (en) * | 1998-01-14 | 2004-03-16 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6709440B2 (en) * | 2001-05-17 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US20050049680A1 (en) * | 2003-09-03 | 2005-03-03 | Fischell Tim A. | Side branch stent with split proximal end |
US6863685B2 (en) * | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
US20060069421A1 (en) * | 2002-01-29 | 2006-03-30 | Medtronic Vascular, Inc. | Flared stent and method for use |
US7160318B2 (en) * | 2001-03-28 | 2007-01-09 | Cook Incorporated | Modular stent graft assembly and use thereof |
US20070067011A1 (en) * | 2005-08-22 | 2007-03-22 | Krolik Jeffrey A | Steep-taper flared stents and apparatus and methods for delivering them |
US20080046072A1 (en) * | 1996-06-06 | 2008-02-21 | Jean-Claude Laborde | Bifurcation stent and method of positioning in a body lumen |
US20080046064A1 (en) * | 1996-06-06 | 2008-02-21 | Jacques Sequin | Endoprosthesis deployment methods for treating vascular bifurcations |
Family Cites Families (153)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US123791A (en) * | 1872-02-20 | Improvement in leveling-jacks for billiard-tables | ||
US72790A (en) * | 1867-12-31 | Island | ||
US3818511A (en) | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
US4390599A (en) | 1980-07-31 | 1983-06-28 | Raychem Corporation | Enhanced recovery memory metal device |
DE3786721D1 (en) | 1986-02-24 | 1993-09-02 | Fischell Robert | DEVICE FOR DETECTING BLOOD VESSELS AND SYSTEM FOR ITS INTRODUCTION. |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US6004346A (en) | 1990-02-28 | 1999-12-21 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5578071A (en) | 1990-06-11 | 1996-11-26 | Parodi; Juan C. | Aortic graft |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
US5064435A (en) * | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
JPH0464367A (en) * | 1990-07-03 | 1992-02-28 | Olympus Optical Co Ltd | Expander for vital duct |
AR246020A1 (en) | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
AU8850391A (en) | 1990-10-18 | 1992-05-20 | Ho Young Song | Self-expanding endovascular stent |
US5356423A (en) | 1991-01-04 | 1994-10-18 | American Medical Systems, Inc. | Resectable self-expanding stent |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
US5443498A (en) | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5234457A (en) | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
US5876445A (en) | 1991-10-09 | 1999-03-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US5456713A (en) | 1991-10-25 | 1995-10-10 | Cook Incorporated | Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting |
US5693084A (en) | 1991-10-25 | 1997-12-02 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
AU669338B2 (en) | 1991-10-25 | 1996-06-06 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5456242A (en) * | 1991-11-19 | 1995-10-10 | Ruholl; Eric J. | Arrow rest for archery bow |
US5316023A (en) | 1992-01-08 | 1994-05-31 | Expandable Grafts Partnership | Method for bilateral intra-aortic bypass |
DK6192A (en) | 1992-01-20 | 1993-07-21 | Engineers & Doctors As | SEGMENTALLY EXPANDABLE TUBULAR ENDOLUMINAL PROSTHESIS |
US5370683A (en) | 1992-03-25 | 1994-12-06 | Cook Incorporated | Vascular stent |
CA2475058C (en) | 1992-10-13 | 2008-12-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5360401A (en) * | 1993-02-18 | 1994-11-01 | Advanced Cardiovascular Systems, Inc. | Catheter for stent delivery |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
SE505436C2 (en) | 1993-04-27 | 1997-08-25 | Ams Medinvent Sa | prostatic stent |
US5549553A (en) | 1993-04-29 | 1996-08-27 | Scimed Life Systems, Inc. | Dilation ballon for a single operator exchange intravascular catheter or similar device |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5669880A (en) | 1993-08-24 | 1997-09-23 | Cordis Corporation | Stent delivery system |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5571135A (en) | 1993-10-22 | 1996-11-05 | Scimed Life Systems Inc. | Stent delivery apparatus and method |
US5989280A (en) | 1993-10-22 | 1999-11-23 | Scimed Lifesystems, Inc | Stent delivery apparatus and method |
US5445646A (en) | 1993-10-22 | 1995-08-29 | Scimed Lifesystems, Inc. | Single layer hydraulic sheath stent delivery apparatus and method |
DE9319267U1 (en) | 1993-12-15 | 1994-02-24 | Vorwerk Dierk Dr | Aortic endoprosthesis |
US5466242A (en) | 1994-02-02 | 1995-11-14 | Mori; Katsushi | Stent for biliary, urinary or vascular system |
US5540701A (en) | 1994-05-20 | 1996-07-30 | Hugh Sharkey | Passive fixation anastomosis method and device |
US5683451A (en) | 1994-06-08 | 1997-11-04 | Cardiovascular Concepts, Inc. | Apparatus and methods for deployment release of intraluminal prostheses |
FR2722678B1 (en) | 1994-07-25 | 1996-12-27 | Braun Celsa Sa B | PLUG-IN MEDICAL PROSTHESIS FOR USE IN THE TREATMENT OF ANEVRISMS, DEVICE COMPRISING SUCH A PROSTHESIS |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
EP0788332B1 (en) | 1994-10-27 | 2000-11-08 | Boston Scientific Limited | Stent delivery device |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
EP0813397A4 (en) | 1995-03-10 | 1999-10-06 | Cardiovascular Concepts Inc | Tubular endoluminar prosthesis having oblique ends |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US5571168A (en) * | 1995-04-05 | 1996-11-05 | Scimed Lifesystems Inc | Pull back stent delivery system |
US5669532A (en) * | 1995-04-07 | 1997-09-23 | United Industries Corporation | Pressure pump for dispensing liquid |
BE1009277A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and method of preparation. |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5534007A (en) * | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
JPH10503411A (en) | 1995-05-25 | 1998-03-31 | メドトロニック・インコーポレーテッド | Stent assembly and method of using the same |
DE69635659T2 (en) | 1995-06-01 | 2006-07-06 | Meadox Medicals, Inc. | IMPLANTABLE INTRALUMINARY PROSTHESIS |
US5788707A (en) | 1995-06-07 | 1998-08-04 | Scimed Life Systems, Inc. | Pull back sleeve system with compression resistant inner shaft |
US5796155A (en) * | 1995-07-14 | 1998-08-18 | The United States Of America As Represented By The Secretary Of The Air Force | Schottky barrier infrared detector array with increased effective fill factor |
US5797951A (en) | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
FR2737969B1 (en) | 1995-08-24 | 1998-01-30 | Rieu Regis | INTRALUMINAL ENDOPROSTHESIS IN PARTICULAR FOR ANGIOPLASTY |
US5562697A (en) | 1995-09-18 | 1996-10-08 | William Cook, Europe A/S | Self-expanding stent assembly and methods for the manufacture thereof |
US5824037A (en) | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5669924A (en) | 1995-10-26 | 1997-09-23 | Shaknovich; Alexander | Y-shuttle stent assembly for bifurcating vessels and method of using the same |
US6348066B1 (en) | 1995-11-07 | 2002-02-19 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
DE69508592T2 (en) | 1995-11-14 | 1999-09-16 | Schneider Europ Gmbh | Stent implantation device |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US6258116B1 (en) | 1996-01-26 | 2001-07-10 | Cordis Corporation | Bifurcated axially flexible stent |
IL117472A0 (en) | 1996-03-13 | 1996-07-23 | Instent Israel Ltd | Radiopaque stent markers |
US6413269B1 (en) | 2000-07-06 | 2002-07-02 | Endocare, Inc. | Stent delivery system |
US6440165B1 (en) | 1996-05-03 | 2002-08-27 | Medinol, Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
US5800514A (en) | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
US6666883B1 (en) | 1996-06-06 | 2003-12-23 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
US5797952A (en) | 1996-06-21 | 1998-08-25 | Localmed, Inc. | System and method for delivering helical stents |
US6077295A (en) | 1996-07-15 | 2000-06-20 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent delivery system |
US6325819B1 (en) | 1996-08-19 | 2001-12-04 | Cook Incorporated | Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm |
US5655548A (en) | 1996-09-16 | 1997-08-12 | Circulation, Inc. | Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion |
US6254628B1 (en) | 1996-12-09 | 2001-07-03 | Micro Therapeutics, Inc. | Intracranial stent |
US5772669A (en) * | 1996-09-27 | 1998-06-30 | Scimed Life Systems, Inc. | Stent deployment catheter with retractable sheath |
US5820542A (en) | 1996-10-31 | 1998-10-13 | Momentum Medical, Inc. | Modified circulatory assist device |
US6682536B2 (en) | 2000-03-22 | 2004-01-27 | Advanced Stent Technologies, Inc. | Guidewire introducer sheath |
US6596020B2 (en) | 1996-11-04 | 2003-07-22 | Advanced Stent Technologies, Inc. | Method of delivering a stent with a side opening |
US5972017A (en) | 1997-04-23 | 1999-10-26 | Vascular Science Inc. | Method of installing tubular medical graft connectors |
US6395017B1 (en) * | 1996-11-15 | 2002-05-28 | C. R. Bard, Inc. | Endoprosthesis delivery catheter with sequential stage control |
US5968052A (en) * | 1996-11-27 | 1999-10-19 | Scimed Life Systems Inc. | Pull back stent delivery system with pistol grip retraction handle |
US5776142A (en) | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
US5910129A (en) | 1996-12-19 | 1999-06-08 | Ep Technologies, Inc. | Catheter distal assembly with pull wires |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5720735A (en) * | 1997-02-12 | 1998-02-24 | Dorros; Gerald | Bifurcated endovascular catheter |
US6096071A (en) | 1998-03-26 | 2000-08-01 | Yadav; Jay S. | Ostial stent |
US6143016A (en) | 1997-04-21 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Sheath and method of use for a stent delivery system |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6409755B1 (en) | 1997-05-29 | 2002-06-25 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
US5984955A (en) | 1997-09-11 | 1999-11-16 | Wisselink; Willem | System and method for endoluminal grafting of bifurcated or branched vessels |
US6231598B1 (en) * | 1997-09-24 | 2001-05-15 | Med Institute, Inc. | Radially expandable stent |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US6330884B1 (en) | 1997-11-14 | 2001-12-18 | Transvascular, Inc. | Deformable scaffolding multicellular stent |
US5961548A (en) | 1997-11-18 | 1999-10-05 | Shmulewitz; Ascher | Bifurcated two-part graft and methods of implantation |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6077296A (en) | 1998-03-04 | 2000-06-20 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6887268B2 (en) * | 1998-03-30 | 2005-05-03 | Cordis Corporation | Extension prosthesis for an arterial repair |
US6520983B1 (en) | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6093203A (en) | 1998-05-13 | 2000-07-25 | Uflacker; Renan | Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation |
US5980533A (en) | 1998-06-09 | 1999-11-09 | Scimed Life Systems, Inc. | Stent delivery system |
US6129738A (en) | 1998-06-20 | 2000-10-10 | Medtronic Ave, Inc. | Method and apparatus for treating stenoses at bifurcated regions |
US6117140A (en) | 1998-06-26 | 2000-09-12 | Scimed Life Systems, Inc. | Stent delivery device |
DE69907686T2 (en) | 1998-07-21 | 2004-02-26 | Biocompatibles Uk Ltd., Farnham | COATING |
US6143002A (en) | 1998-08-04 | 2000-11-07 | Scimed Life Systems, Inc. | System for delivering stents to bifurcation lesions |
US6159239A (en) | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
US6117117A (en) | 1998-08-24 | 2000-09-12 | Advanced Cardiovascular Systems, Inc. | Bifurcated catheter assembly |
US6120522A (en) | 1998-08-27 | 2000-09-19 | Scimed Life Systems, Inc. | Self-expanding stent delivery catheter |
JP3626097B2 (en) * | 1998-11-12 | 2005-03-02 | アドバンスド、カーディオバスキュラー、システムズ、インコーポレーテッド | Improved stent configuration |
US6325820B1 (en) | 1998-11-16 | 2001-12-04 | Endotex Interventional Systems, Inc. | Coiled-sheet stent-graft with exo-skeleton |
US6660030B2 (en) | 1998-12-11 | 2003-12-09 | Endologix, Inc. | Bifurcation graft deployment catheter |
AU1474700A (en) | 1998-12-11 | 2000-06-26 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6733523B2 (en) | 1998-12-11 | 2004-05-11 | Endologix, Inc. | Implantable vascular graft |
JP4332658B2 (en) | 1999-02-01 | 2009-09-16 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | Braided and trifurcated stent and method for producing the same |
WO2000049973A2 (en) | 1999-02-26 | 2000-08-31 | Vascular Architects, Inc. | Coiled stent and catheter assembly |
US5976155A (en) | 1999-03-05 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | System for removably securing a stent on a catheter assembly and method of use |
US6261316B1 (en) | 1999-03-11 | 2001-07-17 | Endologix, Inc. | Single puncture bifurcation graft deployment system |
US6331186B1 (en) | 1999-03-22 | 2001-12-18 | Scimed Life Systems, Inc. | End sleeve coating for stent delivery |
US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
US6146415A (en) | 1999-05-07 | 2000-11-14 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US6648913B1 (en) | 1999-06-07 | 2003-11-18 | Scimed Life Systems, Inc. | Guidewire-access modular intraluminal prosthesis with connecting section |
US6569193B1 (en) | 1999-07-22 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Tapered self-expanding stent |
US6458867B1 (en) | 1999-09-28 | 2002-10-01 | Scimed Life Systems, Inc. | Hydrophilic lubricant coatings for medical devices |
US6613075B1 (en) | 1999-10-27 | 2003-09-02 | Cordis Corporation | Rapid exchange self-expanding stent delivery catheter system |
US6610087B1 (en) | 1999-11-16 | 2003-08-26 | Scimed Life Systems, Inc. | Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
DE60107651T2 (en) * | 2000-01-31 | 2005-05-19 | Advanced Cardiovascular Systems, Inc., Santa Clara | SELF-EXPANDING STENT WITH INCREASED FEEDING ACCURACY |
US6398807B1 (en) | 2000-01-31 | 2002-06-04 | Scimed Life Systems, Inc. | Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor |
US6245100B1 (en) | 2000-02-01 | 2001-06-12 | Cordis Corporation | Method for making a self-expanding stent-graft |
JP3875560B2 (en) | 2000-02-18 | 2007-01-31 | イー・ブイ・アール・エンドバスキュラー・リサーチイズ・エス・エー | Intraluminal device for carrying and inflating an inflatable prosthesis within a lumen |
US6391050B1 (en) * | 2000-02-29 | 2002-05-21 | Scimed Life Systems, Inc. | Self-expanding stent delivery system |
JP2001245886A (en) | 2000-03-02 | 2001-09-11 | Kanegafuchi Chem Ind Co Ltd | Ultrasonic echo catheter within blood vessel |
ES2211791T3 (en) | 2000-03-03 | 2004-07-16 | Cook Incorporated | ENDOVASCULAR DEVICE THAT HAS A STENT. |
US6491681B1 (en) | 2000-04-06 | 2002-12-10 | Scimed Life Systems, Inc. | Handle for use with steerable device for introducing diagnostic and therapeutic elements into the body |
AU2001259429A1 (en) | 2000-05-02 | 2001-11-12 | Wilson-Cook Medical Inc. | Introducer device for catheters o.t.l. with eversible sleeve |
US20030139803A1 (en) | 2000-05-30 | 2003-07-24 | Jacques Sequin | Method of stenting a vessel with stent lumenal diameter increasing distally |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US20020068968A1 (en) * | 2000-08-16 | 2002-06-06 | Thomas Hupp | Virtual stent making process based upon novel enhanced plate tectonics derived from endoluminal mapping |
US6589273B1 (en) | 2000-10-02 | 2003-07-08 | Impra, Inc. | Apparatus and method for relining a blood vessel |
US6908477B2 (en) | 2000-10-13 | 2005-06-21 | Rex Medical, L.P. | Methods of implanting covered stents with side branch |
US6428566B1 (en) | 2000-10-31 | 2002-08-06 | Advanced Cardiovascular Systems, Inc. | Flexible hoop and link sheath for a stent delivery system |
US6545097B2 (en) | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
US20020123791A1 (en) | 2000-12-28 | 2002-09-05 | Harrison William J. | Stent design with increased vessel coverage |
US6736839B2 (en) | 2001-02-01 | 2004-05-18 | Charles Cummings | Medical device delivery system |
US8337540B2 (en) | 2001-05-17 | 2012-12-25 | Advanced Cardiovascular Systems, Inc. | Stent for treating bifurcations and method of use |
US20030130720A1 (en) | 2002-01-08 | 2003-07-10 | Depalma Donald F. | Modular aneurysm repair system |
US7235095B2 (en) | 2002-02-22 | 2007-06-26 | Scimed Life Systems, Inc. | Method and system for deploying multi-part endoluminal devices |
US20030181973A1 (en) | 2002-03-20 | 2003-09-25 | Harvinder Sahota | Reduced restenosis drug containing stents |
WO2004041126A1 (en) | 2002-11-08 | 2004-05-21 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
US20040236409A1 (en) | 2003-05-20 | 2004-11-25 | Pelton Alan R. | Radiopacity intraluminal medical device |
US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
-
2002
- 2002-11-11 US US10/292,385 patent/US8728143B2/en not_active Expired - Fee Related
-
2003
- 2003-05-09 US US10/435,096 patent/US7344556B2/en not_active Expired - Fee Related
- 2003-11-10 JP JP2004551962A patent/JP5142239B2/en not_active Expired - Fee Related
- 2003-11-10 WO PCT/US2003/035714 patent/WO2004043301A1/en active Application Filing
- 2003-11-10 AU AU2003291416A patent/AU2003291416B2/en not_active Ceased
- 2003-11-10 EP EP03768812A patent/EP1560542A4/en not_active Ceased
- 2003-11-10 CA CA002505073A patent/CA2505073A1/en not_active Abandoned
-
2008
- 2008-03-17 US US12/050,068 patent/US20080161903A1/en not_active Abandoned
-
2009
- 2009-10-16 AU AU2009225371A patent/AU2009225371A1/en not_active Abandoned
-
2011
- 2011-10-14 JP JP2011227159A patent/JP5619703B2/en not_active Expired - Fee Related
Patent Citations (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3945052A (en) * | 1972-05-01 | 1976-03-23 | Meadox Medicals, Inc. | Synthetic vascular graft and method for manufacturing the same |
US3805301A (en) * | 1972-07-28 | 1974-04-23 | Meadox Medicals Inc | Tubular grafts having indicia thereon |
US6346118B1 (en) * | 1983-12-09 | 2002-02-12 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
US4562596A (en) * | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4733065A (en) * | 1984-06-27 | 1988-03-22 | Canon Kabushiki Kaisha | Optical head device with diffraction grating for separating a light beam incident on an optical recording medium from a light beam reflected therefrom |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4733665B1 (en) * | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) * | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4806062A (en) * | 1987-10-29 | 1989-02-21 | Maxon Industries, Inc. | Stowable lift for freight vehicles |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5195984A (en) * | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5282824A (en) * | 1990-10-09 | 1994-02-01 | Cook, Incorporated | Percutaneous stent assembly |
US6527789B1 (en) * | 1991-01-28 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5197978B1 (en) * | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
US5197978A (en) * | 1991-04-26 | 1993-03-30 | Advanced Coronary Technology, Inc. | Removable heat-recoverable tissue supporting device |
US5211663A (en) * | 1991-06-24 | 1993-05-18 | Smith & Nephew Richards, Inc. | Passivation methods for metallic medical implants |
US5387235A (en) * | 1991-10-25 | 1995-02-07 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5720776A (en) * | 1991-10-25 | 1998-02-24 | Cook Incorporated | Barb and expandable transluminal graft prosthesis for repair of aneurysm |
US6689159B2 (en) * | 1991-10-28 | 2004-02-10 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5603721A (en) * | 1991-10-28 | 1997-02-18 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US6056776A (en) * | 1991-10-28 | 2000-05-02 | Advanced Cardiovascular System, Inc. | Expandable stents and method for making same |
US5735893A (en) * | 1991-10-28 | 1998-04-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5211658A (en) * | 1991-11-05 | 1993-05-18 | New England Deaconess Hospital Corporation | Method and device for performing endovascular repair of aneurysms |
US5192297A (en) * | 1991-12-31 | 1993-03-09 | Medtronic, Inc. | Apparatus and method for placement and implantation of a stent |
US5755769A (en) * | 1992-03-12 | 1998-05-26 | Laboratoire Perouse Implant | Expansible endoprosthesis for a human or animal tubular organ, and fitting tool for use thereof |
US5510077A (en) * | 1992-03-19 | 1996-04-23 | Dinh; Thomas Q. | Method of making an intraluminal stent |
US5405378A (en) * | 1992-05-20 | 1995-04-11 | Strecker; Ernst P. | Device with a prosthesis implantable in the body of a patient |
US5707376A (en) * | 1992-08-06 | 1998-01-13 | William Cook Europe A/S | Stent introducer and method of use |
US5514178A (en) * | 1993-06-24 | 1996-05-07 | Synthelabo | Prosthesis for bodily canal |
US5632771A (en) * | 1993-07-23 | 1997-05-27 | Cook Incorporated | Flexible stent having a pattern formed from a sheet of material |
US5632772A (en) * | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5609627A (en) * | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US6053941A (en) * | 1994-05-26 | 2000-04-25 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5609605A (en) * | 1994-08-25 | 1997-03-11 | Ethicon, Inc. | Combination arterial stent |
US5499973A (en) * | 1994-09-08 | 1996-03-19 | Saab; Mark A. | Variable stiffness balloon dilatation catheters |
US5755771A (en) * | 1994-11-03 | 1998-05-26 | Divysio Solutions Ulc | Expandable stent and method of delivery of same |
US5632763A (en) * | 1995-01-19 | 1997-05-27 | Cordis Corporation | Bifurcated stent and method for implanting same |
US6358556B1 (en) * | 1995-04-19 | 2002-03-19 | Boston Scientific Corporation | Drug release stent coating |
US6183509B1 (en) * | 1995-05-04 | 2001-02-06 | Alain Dibie | Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device |
US5591228A (en) * | 1995-05-09 | 1997-01-07 | Edoga; John K. | Methods for treating abdominal aortic aneurysms |
US5873904A (en) * | 1995-06-07 | 1999-02-23 | Cook Incorporated | Silver implantable medical device |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US6063113A (en) * | 1995-06-13 | 2000-05-16 | William Cook Europe Aps | Device for implantation in a vessel or hollow organ lumen |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5632762A (en) * | 1995-11-09 | 1997-05-27 | Hemodynamics, Inc. | Ostial stent balloon |
US6533810B2 (en) * | 1995-11-27 | 2003-03-18 | Schneider (Europe) Ag | Conical stent |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US6203568B1 (en) * | 1996-04-05 | 2001-03-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US6702846B2 (en) * | 1996-04-09 | 2004-03-09 | Endocare, Inc. | Urological stent therapy system and method |
US20020035389A1 (en) * | 1996-05-03 | 2002-03-21 | Jacob Richter | Bifurcated stent with improved side branch aperture and method of making same |
US5617878A (en) * | 1996-05-31 | 1997-04-08 | Taheri; Syde A. | Stent and method for treatment of aortic occlusive disease |
WO1997046174A1 (en) * | 1996-06-06 | 1997-12-11 | Jacques Seguin | Vascular bifurcation endoprosthesis |
US20080046064A1 (en) * | 1996-06-06 | 2008-02-21 | Jacques Sequin | Endoprosthesis deployment methods for treating vascular bifurcations |
US20080046072A1 (en) * | 1996-06-06 | 2008-02-21 | Jean-Claude Laborde | Bifurcation stent and method of positioning in a body lumen |
US5749825A (en) * | 1996-09-18 | 1998-05-12 | Isostent, Inc. | Means method for treatment of stenosed arterial bifurcations |
US6692483B2 (en) * | 1996-11-04 | 2004-02-17 | Advanced Stent Technologies, Inc. | Catheter with attached flexible side sheath |
US6210429B1 (en) * | 1996-11-04 | 2001-04-03 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US5749890A (en) * | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
US6030415A (en) * | 1997-01-29 | 2000-02-29 | Endovascular Technologies, Inc. | Bell-bottom modular stent-graft |
US5897588A (en) * | 1997-03-14 | 1999-04-27 | Hull; Cheryl C. | Coronary stent and method of fabricating same |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5904713A (en) * | 1997-07-14 | 1999-05-18 | Datascope Investment Corp. | Invertible bifurcated stent/graft and method of deployment |
US6508836B2 (en) * | 1997-08-13 | 2003-01-21 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6221090B1 (en) * | 1997-08-13 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Stent delivery assembly |
US6361544B1 (en) * | 1997-08-13 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6165195A (en) * | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6221098B1 (en) * | 1997-08-13 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6520988B1 (en) * | 1997-09-24 | 2003-02-18 | Medtronic Ave, Inc. | Endolumenal prosthesis and method of use in bifurcation regions of body lumens |
US6042606A (en) * | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US5891114A (en) * | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US5893887A (en) * | 1997-10-14 | 1999-04-13 | Iowa-India Investments Company Limited | Stent for positioning at junction of bifurcated blood vessel and method of making |
US6503271B2 (en) * | 1998-01-09 | 2003-01-07 | Cordis Corporation | Intravascular device with improved radiopacity |
US6706062B2 (en) * | 1998-01-14 | 2004-03-16 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6042588A (en) * | 1998-03-03 | 2000-03-28 | Scimed Life Systems, Inc | Stent delivery system |
US6019778A (en) * | 1998-03-13 | 2000-02-01 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6179858B1 (en) * | 1998-05-12 | 2001-01-30 | Massachusetts Institute Of Technology | Stent expansion and apposition sensing |
US6514281B1 (en) * | 1998-09-04 | 2003-02-04 | Scimed Life Systems, Inc. | System for delivering bifurcation stents |
US6340368B1 (en) * | 1998-10-23 | 2002-01-22 | Medtronic Inc. | Implantable device with radiopaque ends |
US6059813A (en) * | 1998-11-06 | 2000-05-09 | Scimed Life Systems, Inc. | Rolling membrane stent delivery system |
US6361557B1 (en) * | 1999-02-05 | 2002-03-26 | Medtronic Ave, Inc. | Staplebutton radiopaque marker |
US6197049B1 (en) * | 1999-02-17 | 2001-03-06 | Endologix, Inc. | Articulating bifurcation graft |
US6375676B1 (en) * | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6210431B1 (en) * | 1999-12-10 | 2001-04-03 | John A. Power | Ostial bifurcation lesion stenting catheter |
US6695875B2 (en) * | 2000-03-14 | 2004-02-24 | Cook Incorporated | Endovascular stent graft |
US7686845B2 (en) * | 2000-05-30 | 2010-03-30 | Devax, Inc. | Noncylindrical stent deployment system for treating vascular bifurcations |
US7344556B2 (en) * | 2000-05-30 | 2008-03-18 | Devax, Inc. | Noncylindrical drug eluting stent for treating vascular bifurcations |
US20040006381A1 (en) * | 2000-05-30 | 2004-01-08 | Jacques Sequin | Noncylindrical drug eluting stent for treating vascular bifurcations |
US20020016597A1 (en) * | 2000-08-02 | 2002-02-07 | Dwyer Clifford J. | Delivery apparatus for a self-expanding stent |
US20020028984A1 (en) * | 2000-09-01 | 2002-03-07 | Asahi Kogaku Kogyo Kabushiki Kaisha Tokyo, Japan | Flexible tube for an endoscope and electronic endoscope equipped with the flexible tube |
US6699274B2 (en) * | 2001-01-22 | 2004-03-02 | Scimed Life Systems, Inc. | Stent delivery system and method of manufacturing same |
US7160318B2 (en) * | 2001-03-28 | 2007-01-09 | Cook Incorporated | Modular stent graft assembly and use thereof |
US6863685B2 (en) * | 2001-03-29 | 2005-03-08 | Cordis Corporation | Radiopacity intraluminal medical device |
US6709440B2 (en) * | 2001-05-17 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US20060069421A1 (en) * | 2002-01-29 | 2006-03-30 | Medtronic Vascular, Inc. | Flared stent and method for use |
US20050049680A1 (en) * | 2003-09-03 | 2005-03-03 | Fischell Tim A. | Side branch stent with split proximal end |
US20070067011A1 (en) * | 2005-08-22 | 2007-03-22 | Krolik Jeffrey A | Steep-taper flared stents and apparatus and methods for delivering them |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101501B2 (en) | 1996-06-06 | 2015-08-11 | Biosensors International Group, Ltd. | Bifurcation stent and method of positioning in a body lumen |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
US8603157B2 (en) | 1996-06-06 | 2013-12-10 | Biosensors International Group, Ltd. | Endoprosthesis deployment methods for treating vascular bifurcations |
US7686845B2 (en) | 2000-05-30 | 2010-03-30 | Devax, Inc. | Noncylindrical stent deployment system for treating vascular bifurcations |
US8236041B2 (en) | 2000-05-30 | 2012-08-07 | Biosensors International Group, Ltd. | Noncylindrical stent deployment system for treating vascular bifurcations |
US8231667B2 (en) | 2002-11-08 | 2012-07-31 | Jacques Séguin | Endoprosthesis for vascular bifurcation |
US8864817B2 (en) | 2002-11-08 | 2014-10-21 | Jacques Séguin | Endoprosthesis for vascular bifurcation |
US8197493B2 (en) | 2007-10-17 | 2012-06-12 | Mindframe, Inc. | Method for providing progressive therapy for thrombus management |
US8070791B2 (en) | 2007-10-17 | 2011-12-06 | Mindframe, Inc. | Multiple layer embolus removal |
US10413310B2 (en) | 2007-10-17 | 2019-09-17 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8574262B2 (en) | 2007-10-17 | 2013-11-05 | Covidien Lp | Revascularization devices |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US10835257B2 (en) | 2007-10-17 | 2020-11-17 | Covidien Lp | Methods of managing neurovascular obstructions |
US10016211B2 (en) | 2007-10-17 | 2018-07-10 | Covidien Lp | Expandable tip assembly for thrombus management |
US9387098B2 (en) | 2007-10-17 | 2016-07-12 | Covidien Lp | Revascularization devices |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US9320532B2 (en) | 2007-10-17 | 2016-04-26 | Covidien Lp | Expandable tip assembly for thrombus management |
US8945172B2 (en) | 2007-10-17 | 2015-02-03 | Covidien Lp | Devices for restoring blood flow and clot removal during acute ischemic stroke |
US8945143B2 (en) | 2007-10-17 | 2015-02-03 | Covidien Lp | Expandable tip assembly for thrombus management |
US11786254B2 (en) | 2007-10-17 | 2023-10-17 | Covidien Lp | Methods of managing neurovascular obstructions |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US8940003B2 (en) | 2008-02-22 | 2015-01-27 | Covidien Lp | Methods and apparatus for flow restoration |
US8679142B2 (en) | 2008-02-22 | 2014-03-25 | Covidien Lp | Methods and apparatus for flow restoration |
US9161766B2 (en) | 2008-02-22 | 2015-10-20 | Covidien Lp | Methods and apparatus for flow restoration |
US11529156B2 (en) | 2008-02-22 | 2022-12-20 | Covidien Lp | Methods and apparatus for flow restoration |
US10456151B2 (en) | 2008-02-22 | 2019-10-29 | Covidien Lp | Methods and apparatus for flow restoration |
US8545514B2 (en) | 2008-04-11 | 2013-10-01 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
KR101073035B1 (en) * | 2009-05-13 | 2011-10-12 | 연세대학교 산학협력단 | H Side-branch Stent |
US20110054438A1 (en) * | 2009-08-28 | 2011-03-03 | Webster Mark W I | Stent delivery at a bifurcation, systems and methods |
US8663315B2 (en) * | 2009-11-12 | 2014-03-04 | Industry-Academic Cooperation Foundation, Yonsei University | Stent for protecting bifurcated blood vessels in bifurcation lesion |
US20120283821A1 (en) * | 2009-11-12 | 2012-11-08 | Industry-Academic Cooperation Foundation, Yonsei University | Stent for Protecting Bifurcated Blood Vessels in Bifurcation Lesion |
CN108836585A (en) * | 2018-05-28 | 2018-11-20 | 上海长海医院 | A kind of absorbable Y type carotid stents from Tu Mo branch of band |
WO2023018892A1 (en) * | 2021-08-12 | 2023-02-16 | Tomasian Douglas A | Left coronary artery stent system, stent assembly and method therefore |
Also Published As
Publication number | Publication date |
---|---|
JP2006505361A (en) | 2006-02-16 |
EP1560542A1 (en) | 2005-08-10 |
AU2003291416A1 (en) | 2004-06-03 |
AU2009225371A1 (en) | 2009-11-05 |
EP1560542A4 (en) | 2009-01-07 |
AU2003291416B2 (en) | 2009-11-05 |
CA2505073A1 (en) | 2004-05-27 |
JP5142239B2 (en) | 2013-02-13 |
JP5619703B2 (en) | 2014-11-05 |
JP2012030109A (en) | 2012-02-16 |
US20040006381A1 (en) | 2004-01-08 |
US7344556B2 (en) | 2008-03-18 |
US20030139796A1 (en) | 2003-07-24 |
WO2004043301A1 (en) | 2004-05-27 |
US8728143B2 (en) | 2014-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7344556B2 (en) | Noncylindrical drug eluting stent for treating vascular bifurcations | |
US8236041B2 (en) | Noncylindrical stent deployment system for treating vascular bifurcations | |
US7686846B2 (en) | Bifurcation stent and method of positioning in a body lumen | |
US20030139803A1 (en) | Method of stenting a vessel with stent lumenal diameter increasing distally | |
US11065141B2 (en) | Reconstrainment band with reduced removal interference |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BIOSENSORS INTERNATIONAL GROUP, LTD., BERMUDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEVAX, INC.;REEL/FRAME:025414/0644 Effective date: 20101020 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |